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ABSTRACT 
CONTROLLED OXYGEN ACTIVATION IN HUMAN OXYGEN SENSOR FIH 
 
SEPTEMBER 2011 
 
EVREN SABAN, B.S., BILKENT UNIVERSITY 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Michael J. Knapp 
 
 
One of the primary oxygen sensors in human cells, which controls gene expression by 
hydroxylating the hypoxia inducible transcription factor (HIF) is the factor inhibiting 
HIF (FIH). As FIH is an alpha-ketoglutarate dependent non-heme iron dioxygenase, 
oxygen activation is thought to precede substrate hydroxylation. The coupling between 
oxygen activation and substrate hydroxylation was hypothesized to be very tight, in order 
for FIH to fulfill its function as a regulatory enzyme.  Coupling was investigated by 
looking for reactive oxygen species production during turnover. Alkylsulfatase (AtsK), a 
metabolic bacterial enzyme with a related mechanism and similar turnover frequency, 
was used for comparison, and both FIH and AtsK were tested for H2O2, O2
-
 and OH
•
 
formation under steady and substrate-depleted conditions. Coupling ratios were 
determined by comparing the ratio of substrate consumed to product formed. AtsK 
reacted with O2 on the seconds timescale in the absence of prime substrate, and 
uncoupled during turnover to produce H2O2; neither O2
-
 nor OH
•
 were detected.  In 
contrast, FIH was unreactive toward O2 on the minutes timescale in the absence of prime 
substrate, and tightly coupled during steady-state turnover; any reactive oxygen species 
produced by FIH was not available for detection.  Inactivation mechanisms of these 
enzymes were also investigated. AtsK likely inactivated due to deoligomerization, 
vii 
 
whereas FIH inactivated by slow autohydroxylation. Autohydroxylated FIH could not be 
reactivated by dithiothreitol (DTT) nor is ascorbate, suggesting that autohydroxylation 
likely to be irreversible under physiological conditions. 
 
Iron in the FIH active site is coordinated by a (His2Asp) facial triad, KG, and H2O. 
Hydrogen bonding between the facial triad, the HIF-Asn
803
 sidechain, and various 
second-sphere residues suggests a functional role for the second coordination sphere in 
tuning the chemistry of the Fe(II) center.  Point mutants of FIH were prepared to test the 
functional role of the KG-centered (Asn205, Asn294) or HIF-Asn803 centered (Arg238, 
Gln
239
) second-sphere residues.  The second sphere was tested for local effects on 
priming Fe(II) to react with O2, oxidative decarboxylation, and substrate positioning.  
Steady-state kinetics were used to test for overall catalytic effects, autohydroxylation 
rates were used to test for priming and positioning, and electronic spectroscopy was used 
to assess the primary coordination sphere and the electrophilicity of KG.  Asn205Ala 
and Asn
294Ala exhibited diminished rates of steady-state turnover, while minimally 
affecting autohydroxylation, consistent with impaired oxidative decarboxylation.  Blue 
shifted MLCT transitions for (Fe+KG)FIH indicated that these point mutations 
destabilized the * orbitals of KG, further supporting a slowed rate of oxidative 
decarboxylation. The Arg
238Met mutant exhibited steady-state rates too low to measure 
and diminished product yields, suggesting impaired substrate positioning or priming; 
Arg
238Met was capable of O2-activation for the autohydroxylation reaction.  The 
Gln
239Asn mutant exhibited significantly slowed steady-state kinetics and diminished 
product yields, suggesting impaired substrate positioning or priming.  As HIF binding to 
viii 
 
Gln
239Asn stimulated autohydroxylation, it is more likely that this point mutant simply 
mis-positions the HIF-Asn
803
 sidechain. By combining kinetics and spectroscopy, it was 
shown that these second sphere hydrogen bonds play roles in promoting oxidative 
decarboxylation, priming Fe(II) to bind O2, and positioning HIF-Asn
803
. 
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CHAPTER 1 
KEY PLAYERS OF OXYGEN SENSING   
1.1 Introduction 
Molecular oxygen has a prime function in aerobes. It is the final electron acceptor in 
cellular aerobic respiration system to produce energy in the form of ATP. Energy 
production starts with glycolysis in cytoplasm and continues with oxidative 
decarboxylation of pyruvate, citric acid cycle and oxidative phosphorylation steps in 
mitochondria. Most of the ATP synthesis occurs in the last step in which oxygen is the 
terminal electron acceptor in electron transport chain. During glycolysis 2 ATP molecules 
are produced whereas 36 ATP molecules are formed with the help of molecular oxygen 
(1). Due to its high energy potential, oxygen is crucial for our life. Oxygen does not only 
play a key role in energy metabolism, it is also used as a substrate for the production of 
key cellular components in signaling. So this makes molecular oxygen even more 
important in our life.  
 
A Constant source of energy is necessary to maintain our lives, but oxygen 
concentrations may vary due to environmental conditions or due to the type of tissues in 
which O2 is distributed throughout the human body (2, 3).  Lack of oxygen for brief 
periods of time can be tolerated, but a continuous lack of oxygen requires more 
complicated responses (4). An adaptive response to the lack of oxygen   in an effort to 
maintain energy requirements is called oxygen homeostasis (2). At high altitudes oxygen 
levels can decrease up to 30% due to air density and our bodies respond to this new 
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environment by triggering more red blood cell production so that more oxygen can be 
delivered to the cells. Low oxygen concentrations might also occur locally in our body as 
in the case of tumorous cells. They need oxygen to grow, so the adaptive response to lack 
of oxygen is to trigger angiogenesis.  
1.2 Hypoxia Inducible Factor 
When dioxygen levels change in a cellular environment, adaptation to a new environment 
is achieved by the transcriptional factor HIF. Under hypoxia (when dioxygen levels are 
low), HIF-1 induces the expression of over 100 genes associated with angiogenesis in 
cancer, immune response, erythropoiesis, energy metabolism, nutrient transport and cell 
migration (5-12). HIF is a heterodimeric transcription factor consisting of a constitutively 
expressed HIF-β subunit and oxygen regulated HIF-α subunit (13-15). There are three 
isoforms of HIF which are HIF-1, HIF-2 and HIF-3 in which HIF-1 is the most important 
and abundant and they are accepted as the master regulators in oxygen homeostasis (16-
19). HIF-1α/β proteins contain basic-helix-loop-helix and Per-ARNT-SIM (bHLH-PAS) 
domains for DNA binding and heterodimerization (9). Studies showed that both bHLH 
and PAS domains are required for complex formation and DNA binding. Truncation of 
one of the domains revealed that bHLH can dimerize alone but the PAS domain is also 
required for DNA binding (20). HIF-1α also has oxygen dependent degradation (ODDD) 
and transcriptional activation domains (NTAD and CTAD). These domains are required 
for the regulation of HIF activity in the presence of normal oxygen levels (Figure 1.1) 
(14, 21, 22).  
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Figure 1.1: HIF-1α/β domains 
 
Under hypoxic conditions HIF-1α levels rise and HIF-1α dimerizes with HIF-1β and 
initiates transcriptional activation. To activate gene transcription, the heterodimeric HIF-
1α/β complex requires coactivators including p300, CBP, SRC-1 and TIF2. Once the 
active transcription complex forms, it binds to a core DNA motif (G/ACGTG) in hypoxia 
response elements (HREs) that are associated by HIF target genes. This results the 
induction of over 100 genes including angiogenesis, erythropoiesis, vascular remodeling, 
inflammation and other processes to achieve oxygen homeostasis (23). 
1.3 HIF Hydroxylases 
At normal oxygen levels HIF activity is regulated either by proteasomal degradation or 
prevention of coactivator binding. The key players in hypoxic response are the HIF 
hydroxylases, which regulate the activity level of HIF by dioxygen dependent 
modification under conditions of normal or elevated oxygen (7, 24-26). The regulation of 
HIF is shown in Figure 1.2. 
1.3.1 Prolyl Hydroxylase 
Two types of modification have been identified both of which inhibit HIF. In the first 
type of modification, the ODD domain of HIF-1α is hydroxylated at proline residues 
4 
 
(Pro-402 and Pro-564 in HIF-1α), which are mediated by PHD (Prolyl hydroxylase). The 
ODD domain possesses two sub-domains, NODD and CODD (N- and C- terminal ODD) 
each of which can be independently hydroxylated. This hydroxylation enables the 
recognition of modified HIF-1α ODD domain by von Hippel-Lindau tumor suppressor 
protein (pVHL) by increasing the affinity between these proteins. The hydroxylated 
proline residue excludes a water molecule and forms two hydrogen bonds with Ser-111 
and His-115 residues of pVHL which makes this complex more stable. Ubiquitin ligase 
binds this complex and ubiquitinylates and targets HIF-1α for hydrolysis via ubiquitin-
proteasome pathway (27, 28).  
1.3.2 Factor Inhibiting HIF 
In the second type of modification, the C-terminal transactivation domain (CTAD) of 
HIF-1α is hydroxylated at the β-Carbon of asparagine residue (Asn-803) by FIH (factor 
inhibiting HIF) in a process which is independent of ODD modification (29-32). 
Hydroxylation at this asparagine residue prevents interaction of HIF-1α with the CH-1 
(Cysteine/Histidine rich) domain of the transcriptional co-activator p300. NMR structures 
of unhydroxylated CTAD bound to CH-1 of p300 showed that Asn-803 residue is buried 
at the complex interface, and this suggests that hydroxylation of β-Carbon of Asn-803 
may decrease binding affinity either by disrupting the interaction between pVHL and 
HIF-1α and/or disrupting the α-helix structure of CTAD formed at the binding interface 
(30, 33, 34). 
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Figure 1.2 HIF pathway 
 
Subtle changes in the oxygen concentrations in our body are sensed by these HIF 
hydroxylases. There are three isoforms of PHD enzyme (PHD1, PHD2 & PHD3) and 
with FIH; all four enzymes exist at different concentrations and in different 
compartments of cells. The activity of these enzymes depends on the available oxygen 
concentration and they are accepted as the primary oxygen sensors in our body. Generally 
Km of oxygen for these enzymes are higher than the ambient oxygen levels, so small 
changes in the oxygen concentration have large impacts on the activity of these enzymes. 
Km(O2) of FIH was determined to be less than for PHD enzymes. This suggests that HIF-
1α which survived from the degradation pathway can continue to be regulated by FIH 
when PHD activity has already been suppressed by lowered O2 levels (35-37).The HIF 
hydroxylases have different tissue distributions in our body at RNA level. PHD1 is 
abundant in testis, PHD2 and FIH are ubiquitous and PHD3 exist mostly in heart and 
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smooth muscles. Within the cell, PHD1 is nuclear, PHD2 and FIH are mainly in 
cytoplasm, and PHD3 is present both in nucleus and cytoplasm (38-42). Our body has a 
different number of copies of these enzymes, PHD2 is the most abundant and active 
among PHDs; together with FIH, they keep the system under check at all times by 
sensing small changes in available oxygen levels (4, 43).  
1.3.3 Proposed Reaction Mechanism of FIH 
The HIF-hydroxylases (FIH and PHD) belong to the Fe(II) and α-ketoglutarate (αKG) 
dependent dioxygenase superfamily. These enzymes are characterized by their jelly-roll 
motif in which eight anti-parallel β-strands form two β-sheets and Fe(II) is coordinated 
by the His2(Asp/Glu) residues between β-sheets. Unlike heme-containing enzymes, Fe(II) 
forms a facial triad with His2(Asp/Glu); leaving the other three coordination sites for 
reaction chemistry. They consume molecular oxygen and α-ketoglutarate to produce CO2 
and succinate while hydroxylating the primary substrate (R-H) to give product (R-OH) 
with a simplified reaction shown below (32, 44-53).  
 
αKG + O2 + RH → succinate + CO2 + ROH 
 
A consensus mechanism, which is shown in Scheme 1.1, has been proposed for FIH 
based on other αKG dependent enzymes. In the resting enzyme, Fe(II) is six coordinate 
which has 2-His-1-carboxylate facial triad and three water molecules bound. Initially the 
substrate α-ketoglutarate binds to the iron, releasing the two water molecules. Upon 
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primary substrate binding, the last water molecule leaves, making Fe(II) five-coordinated 
and creating an open coordination site for molecular oxygen.  
 
 
Scheme 1.1 Consensus reaction mechanism of FIH   
 
Fe(II) is relatively unreactive toward molecular oxygen unless the coordination of metal 
center changes from six- to five-coordinate and when this happens the quaternary 
complex composed of Fe(II), α-ketoglutarate and substrate bound to the enzyme active 
site reacts with dioxygen. Because six coordinate Fe(II) is not reactive towards O2, 
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substrate binding is accepted as the switch which activates Fe(II) for oxygen activation.  
First, Fe(II) activates oxygen by one-electron reduction to form a superoxide radical, 
which attacks C2 of α-ketoglutarate. The decarboxylation of α-ketoglutarate yields 
succinate and CO2 with the concomitant formation of a highly reactive Fe(IV)=O 
intermediate (54-58). This reactive intermediate then abstracts a hydrogen atom from the 
primary substrate forming a substrate-centered radical. Finally, this radical binds the 
oxygen on the iron center and generates the final hydroxylated product and the enzyme 
returns to its Fe(II) active state. This final step is called a hydrogen abstraction - rebound 
mechanism (59-64).  
1.4 α-Ketoglutarate Dependent Enzymes 
The members of the α-ketoglutarate dependent dioxygenase family exist both in 
prokaryotes and eukaryotes and catalyze a wide range of reactions in which 
hydroxylation chemistry is the main reaction.  These enzymes are accepted as 
dioxygenases but individual atoms of dioxygen are distributed to different products; one 
oxygen atom is incorporated into product while the other oxygen atom is incorporated 
into succinate that is derived from α-ketoglutarate. While the typical reaction is the 
hydroxylation, other oxidative processes like ring closure, ring opening, desaturation, 
elimination and epoxidation reactions are also common in this class of enzymes. In some 
of these reactions it is possible that one atom of dioxygen is incorporated into succinate, 
and the other oxygen atom is liberated as a water molecule.  These enzymes are a part of 
important biological processes including post-translational modification of proteins, 
DNA repair, antibiotic biosynthesis and fatty acid metabolism, and they all posses α-
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ketoglutarate dependent non-heme Fe(II) active site with His2Asp/Glu facial triad (44, 47, 
65, 66).    
 
α-Ketoglutarate dependent enzymes are only a subfamily of the non-heme iron enzyme 
superfamily, which possesses His2Asp/Glu facial triad and catalyzes many diverse 
reactions. The diversity of these catalyzed reactions is broader than the reactions 
associated with heme-containing enzymes. The porphyrin of heme occupies four 
coordination sites of Fe and one proximal residue binds the fifth coordination site; 
leaving only one available site for binding which is for molecular oxygen. However in 
non-heme enzymes Fe is coordinated by three endogenous protein ligands forming a 
facial triad, and leaving the other three coordination sites for exogenous ligands such as 
oxygen, substrate and/or cofactor. This facial triad combined with the protein flexibility 
tunes the reactivity of active center and makes these enzymes versatile (67). This 
superfamily can be categorized into five families based on the reaction they catalyze 
and/or cofactors they use. These families are the extradiol cleaving catechol 
dioxygenases, Rieske dioxygenases, α-ketoglutarate dependent dioxygenases, 
tetrahydropterin dependent hydroxylases and biosynthetic oxidases (45, 46, 61, 62, 68).  
1.5 Extradiol Cleaving Catechol Dioxygenases 
Extradiol cleaving catechol dioxygenases catalyze the ring cleavage reactions of aromatic 
compounds (48-50). Aromatic ring cleavage of catechols occurs at C-C bond adjacent to 
enediol group and both atoms of molecular oxygen are incorporated into the product via 
four-electron oxidation. The best characterized enzyme in this class is 
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homoprotocatechuate 2,3-dioxygenase (HPCD). To better characterize this enzyme 4-
nitrocatechol was used as an alternative substrate instead of homoprotocatechnic acid 
(HPCA). Crystal structure studies revealed three different intermediates during the 
catalytic cycle. The first one is Fe(II)-O2 complex which showed that Fe-O bond length is 
long (2.4 Å) and the 4-nitrocatechol ring is not planar. This suggests that iron remains in 
the Fe(II) state and substrate gives an electron to activate oxygen. The second 
intermediate is an Fe(II)-peroxo-substrate complex in which oxygen attacks to C2 of 4-
nitrocatechol forming a peroxo bridge. The third and final intermediate is the Fe(II)-
product complex (Scheme 1.2). During the catalytic turnover, the reaction is driven by 
not only close coupling of the iron center and the substrate, but also the second sphere 
residues.    
   
Scheme 1.2 Extradiol catechol dioxygenase catalytic cycle  
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There are two important second sphere residues (Tyr257 and His200), which form 
hydrogen bonds to stabilize the deprotonated substrate and promote heterolytic dioxygen 
bond cleavage, respectively (69-75). 
1.6 Rieske Dioxygenases 
Rieske dioxygenases catalyze the cis-dihydroxylation of aromatic compounds, which in 
turn become catechols during the downstream processes (76). The active site of these 
enzymes differs slightly from other non-heme enzymes in a way that Asp in the facial 
triad binds in a bidentate manner. The two other coordination sites are generally occupied 
with solvent molecules (77, 78). Near the active site, there is a Rieske type cluster (Fe2-
S2), which acts as an external electron source. For the cis-dihydroxylation reaction two 
external electrons are needed, and these are supplied by NADH. A good example for this 
class of enzymes is naphthalene dioxygenase (NDO). Single turnover and 
crystallographic studies of NDO showed that at the end of one turnover both metal 
centers are fully oxidized. For another turnover these centers must be reduced by NADH 
(79, 80). The activated oxygen is proposed to be Fe(III)-hydroperoxo, in which O-O bond 
cleavage occurs and the hydroxylating reagent Fe(V)-oxo-hydroxo is formed, or it can 
directly react with the aryl substrate via a radical mechanism. The proposed reaction 
mechanism is shown Scheme 1.3. The yield of NDO catalytic cycle in the presence of 
alternate substrate benzene is about 50%. Oxygen consumption and benzene 
hydroxylation are not tightly coupled, and hydrogen peroxide is released during the 
turnover. Studies showed that hydrogen peroxide released acts as an inactivator, and it is 
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proposed that this occurs via a Fenton-type reaction forming strong reactive oxygen 
species like hydroxyl radicals (OH˙) (81-84). 
 
Scheme 1.3 Proposed Reaction mechanism of Naphthalene 1,2-dioxygenase  
1.7 Tetrahydropterin Dependent Hydroxylases 
Tetrahydropterin dependent hydroxylases catalyze the hydroxylation of aromatic amino 
acid residues using tetrahydropterin as a two-electron donor cofactor like α-ketoglutarate 
dependent enzymes. Tryptophan (TrpH), tyrosine (TryH) and phenylalanine (PheH) 
hydroxylases are responsible for the formation of the neurotransmitters serotonin and 3,4-
dihydroxyphenylalanine, and the amino acid tyrosine, respectively (85, 86). Binding of 
substrate and cofactor near the iron active site leaves an open coordination site for 
oxygen (Scheme 1.4). Once dioxygen binds, it forms a peroxo bridge between Fe(II) 
center and the cofactor. Heterolytic O-O bond cleavage of this peroxo bridge yields 4a-
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hydroxypterin and an Fe(IV)=O species (87, 88). So two electrons come from cofactor 
and the other two electrons are supplied by Fe(II). Once the Fe(IV)=O intermediate 
forms, it can abstract a hydrogen from the near substrate. The active hydroxyl group then 
rebounds to the radical substrate like in the α-ketoglutarate dependent enzymes (89). 
When the substrate is not present near the active site, the enzyme chooses another 
pathway to protect itself from reactive oxygen species. In the absence of a hydroxylation 
reaction, two tetrahydropterin molecules are oxidized to dihydropterins per molecule of 
dioxygen consumed. The four-electron reduction of dioxygen to water prevents reactive 
oxygen species formation like hydrogen peroxide (90, 91).  
 
 
 
           Scheme 1.4 Reaction mechanism of Aromatic aminoacid hydroxylases  
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1.8 Biosynthetic Oxidases 
Biosynthetic oxidases are a family of enzymes that play key roles in the synthesis of 
biologically important molecules. In this family, substrates bind to the iron center like in 
extradiol dioxygenases, and using electrons from the substrate and/or a cofactor, oxygen 
is reduced to two water molecules in a four-electron reduction with the concomitant 
substrate catalysis. The best known example of this family is isopenicillin-N synthase 
(IPNS). IPNS catalyzes the synthesis of isopenicillin-N from δ-(L-α-aminoadipoyl)-L-
cysteinyl-D-valine (ACV), which is a key step in biosynthesis of penicillin and 
cephalosporin antibiotics (92).  
 
 
Scheme 1.5 Catalytic cycle of IPNS 
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When substrate (ACV) and oxygen bind to iron active site, it is proposed that Fe(III)-
superoxo forms and electron transfer from substrate is promoted which causes the β-
lactam ring closure, formation of the first water molecule and the Fe(IV)=O reactive 
intermediate. The Fe(IV)=O then causes the second ring closure and formation of the 
second water molecule (Scheme 1.5).   
 
Kinetic studies showed that IPNS has no detectable uncoupling between oxygen 
depletion and ACV consumption, but the enzyme inactivates itself slowly with time. It is 
proposed that IPNS is vulnerable to oxidative damage, which is irreversible and cannot 
be rescued by reducing agents. Catalase protects IPNS from damage and reduces the 
inactivation to some extent, which suggests H2O2 formation. Since catalase does not 
rescue the enzyme at 100%, it is concluded that internal ROS formation also gives rise to 
oxidative damage near active site (93, 94).  
 
Other examples of biosynthetic oxidases family are aminocyclopropane carboxylate 
oxidase (ACCO) and fosfomycin oxidase (FOS), which catalyze synthesis of the plant 
hormone ethylene and the fosfomycin antibiotic respectively. Unlike IPNS, these 
enzymes use two electrons from from substrate and two electrons from cofactors (ACCO 
uses ascorbic acid and FOS uses NADH) (67).    
1.9 Activated Oxygen 
As seen from the previously mentioned examples, mononuclear non-heme iron enzymes 
all possess His2Asp/Glu facial triad and catalyze very diverse reactions by utilizing O2. 
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Compared to heme proteins, the non-heme iron active site can accommodate more than 
one ligand. The facial triad occupies generally three coordination sites in these enzymes 
leaving the other three coordination sites for binding of O2 and, in some cases, substrate 
or cofactor. All these enzymes activate dioxygen in different ways. The observed and 
proposed iron-oxo species are as the following: Fe(II)-superoxo, Fe(III)-hydroperoxo, 
Fe(III)-superperoxo and Fe(II)-alkylperoxo intermediates are converted to high valent 
Fe(IV)=O and Fe(V)=O-OH after O-O bond cleavage (67). Activated oxygen and 
reactive intermediates are summarized in Figure 1.3 and Figure 1.4. 
 
Figure 1.3 activated dioxygen in nonheme iron enzymes  
 
17 
 
 
Figure 1.4 Reactive iron-oxo intermediates in nonheme iron enzymes 
 
It would be interesting to understand how these enzymes control reactive iron-oxo 
intermediates when dioxygen is activated. If the oxygen activation is not coupled with the 
substrate catalysis, side reactions can occur. Reactive iron-oxo intermediates can attack 
internal amino acid residues causing self-hydroxylation and self-inhibition or they can 
produce reactive oxygen species (ROS) like H2O2, O2
-, and ˙OH and give oxidative 
damage to their environment.  
 
In α-ketoglutarate dependent enzymes the proposed and, in some cases, observed 
intermediates are Fe(III)-peroxo and Fe(IV)=O intermediates. If the catalytic cycle is not 
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tightly coupled, H2O2 and O2
-
 can be formed, likely from an Fe(III)-peroxo intermediate. 
As the catalytic turnover proceeds, ˙OH can also be formed after Fe(IV)=O step.  
1.10 Coupling of Turnover 
The active site structure including the second coordination sphere plays a key role in the 
reaction turnover. The protein flexibility, substrate binding, electron donating cofactor, 
second sphere residues and facial triad are all important players during the catalytic cycle. 
Any oxygen leakage can be avoided by coupling the dioxygen activation to the 
hydroxylation step so that the reaction is driven to the product without byproducts. 
However, uncoupling of oxygen activation to substrate hydroxylation can occur. The 
ideal stoichiometric ratio between oxygen consumption and product catalysis would be 
1:1. Any oxygen leakage would cause more oxygen consumption and the stoichiometry 
would be higher than 1 in which reactive oxygen species can be generated or the enzyme 
can hydroxylate itself. Self hydroxylation generally occurs when the substrate is not 
present or not in the close proximity of iron active site. In the case of FIH, the rate of 
self-hydroxylation is diminished when the substrate CTAD is present. If the regulatory 
role of FIH in oxygen sensing is considered, uncoupling between oxygen activation and 
product catalysis must be low such that no excess reactive oxygen should give oxidative 
damage. The release of reactive oxygen species should also be minimal in order to 
prevent oxidative stress in the cells. Determining the extent of uncoupling and the 
propensity to produce ROS in FIH will help us to understand the link between oxygen 
activation and product hydroxylation.  
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1.11 Second Coordination Sphere  
In order to determine how FIH controls activated oxygen, second coordination sphere 
residues should also be investigated. These residues play important roles in hydroxylation 
chemistry in which they tune the active site by making hydrogen bonds. The hydrogen 
bonding network with the second coordination sphere can also be found in other 
enzymes. In the case of FIH, there are four residues present in the second sphere which 
control the hydroxylation by either facilitating the decarboxylation of α-ketoglutarate or 
positioning the primary substrate. When activated oxygen attacks αKG, a buildup of 
negative charge can be pulled away by hydrogen bond donors in the second sphere so 
that decarboxylation can be facilitated. Subsequent to decarboxylation, hydroxylation of 
the primary substrate occurs via the hydrogen abstraction/rebound mechanism involving 
a putative Fe(IV)=O intermediate. It is crucial that the substrate is oriented in the correct 
position for hydroxylation. Hydrogen bonding networks in the second sphere provide 
stabilization for optimal orientation of the substrate.  
 
Because of the simpler substrate requirements of AtsK, this enzyme will also be studied 
and compared with FIH. AtsK is a metabolic αKG-dependent dioxygenase involved in 
bacterial sulfur metabolism. Under sulfur starvation conditions, AtsK catalyzes the 
hydroxylation of alkylsulfate and releases inorganic sulfate to the medium. Hexylsulfate 
is hydroxylated to form 1-hydroxylhexylsulfate which decomposes spontaneously to 
hexanal and inorganic sulfate (95).  
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How FIH controls activated O2, and the role of the second sphere residues on 
hydroxylation, will be the focus of this research. The steps between O2 binding and 
decarboxylation are very important because the enzyme turnover rate is determined by 
these steps and it is related to the O2 sensing function of FIH. So it is crucial to 
understand how oxygen activation is controlled by FIH, which performs its unique 
oxygen sensing role in our body.  
1.12 Appendix 
1.12.1 Abbreviations 
HIF, Hypoxia Inducible Factor; 
ODDD, Oxygen Dependent Degradation Domain; 
N- and C- terminal TAD, Transcriptional activation domain of HIF-1α  
p300, Transcriptional coactivator; 
CBP, CREB-binding protein; 
SRC-1, Steroid receptor coactivator 1; 
TIF2, Transcriptional intermediary factor 2; 
HRE, Hypoxia responsive elements; 
pVHL, Von Hippel-Lindau tumor suppressor; 
PHD, Prolyl hydroxylase; 
FIH, Factor inhibiting HIF; 
HPCD, Homoprotocatechuate 2,3-dioxygenase; 
HPCA, Homoprotocatechnic acid; 
NDO, Naphthalene dioxygenase; 
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TrpH, Tryptophan hydroxylase; 
TryH, Tyrosine hydroxylase; 
PheH, Phenylalanine hydroxylase; 
IPNS, Isopenicillin-N synthase; 
ACV, δ-(L-α-aminoadipoyl)-L-cysteinyl-D-valine; 
ACCO, aminocyclopropane carboxylate oxidase; 
FOS, Fosfomycin oxidase; 
AtsK, alkylsulfatase; 
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CHAPTER 2 
UNCOUPLED O2-ACTIVATION IN THE HUMAN HIF-ASPARAGINYL 
HYDROXYLASE, FIH, DOES NOT PRODUCE REACTIVE OXYGEN 
SPECIES 
2.1 Introduction 
Cellular oxygen-sensing in metazoans is directly controlled by enzymes which 
hydroxylate the alpha-subunit of the hypoxia inducible factor (HIFα or HIF-1α) (1-3).  As 
the HIF-hydroxylases are key regulators of angiogenesis and basal metabolism, they are 
potential targets for treating diseases such as cancer and stroke (4-6).  The two types of 
HIF-hydroxylase are the factor inhibiting HIF-1 (FIH) and prolyl hydroxylase (PHD) (7-
9), both of which are Fe(II), α-ketoglutarate-dependent hydroxylases.  The best 
characterized of these enzymes is the human enzyme FIH, which hydroxylates the Asn
803
 
residue within the C-terminal transactivation domain (CTAD) of HIFα (10), thereby 
preventing transcriptional machinery from binding to HIFα.   
 
αKG hydroxylases catalyze two half-reactions resulting in the transfer of oxidizing 
equivalents from O2 to both αKG and the primary substrate (Scheme 2.1) (4, 11, 12).  
The first half-reaction is O2-activation, in which the αKG/[Fe]
2+
 is oxidatively 
decarboxylated to form succinate/[FeO]
2+
 and CO2 (13, 14).  The second half-reaction is 
transfer of the oxidant from [FeO]
2+
 to the prime substrate (15, 16), which may include 
reactions such as desaturation, demethylations, ring-closure, and hydroxylation (11, 12, 
17); in the case of FIH, this reaction is the hydroxylation of the β-carbon of Asn803 (10). 
Tight coupling between these two half-reactions is challenging, and many of the αKG-
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dependent hydroxylases exhibit reactions with O2 that are uncoupled (18-26).  In some 
cases this leads to auto-hydroxylation of residues within enzyme active sites (18, 21, 22, 
25), however, more commonly, it leads to metal oxidation that can be rescued by 
ascorbate (12, 23, 26).  
 
Scheme 2.1 Consensus chemical mechanism of αKG-dependent hydroxylases.  The 
(Fe+KG)Enzyme binds the primary substrate to form the ES complex.   
 
The prevailing model for how αKG hydroxylases may achieve coupled turnover focuses 
on changes in the coordination number about the Fe(II) upon substrate binding. In this 
model, the Fe(II) is six-coordinate prior to prime substrate binding, coordinated by a 
His2(Asp/Glu) facial triad, a bidentate αKG, and a single H2O ligand.  Once the prime 
substrate binds, the H2O ligand (17) is released to form a five-coordinate Fe(II) center 
which is ready to react with O2.  Crystal structures of several αKG hydroxylases support 
this model (12, 27-29), as does mechanistic data indicating that poor substrates stimulate 
uncoupling (20, 24, 26, 30).  Perhaps the strongest evidence comes from advanced 
spectroscopic studies that clearly show this coordination change occurs upon substrate 
binding (31-33).  Tight coupling would be highly beneficial to an O2-sensing enzyme, 
such as FIH.   
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There are three criteria for effective O2-sensing by HIF hydroxylases. First, the KM(O2) 
should lie above the physiological pO2, so that the rate of HIF hydroxylation is 
proportional to the pO2.  As the reported KM(O2) for FIH is much higher than the cellular 
pO2 under physiological conditions (34, 35), it appears that FIH is well suited for its 
regulatory role by this first criterion.  Second, uncoupling between the two half-reactions 
must be low, ideally such that no molecule of O2 reacts without HIF hydroxylation, due 
to the potential for oxidative damage.  Although αKG hydroxylases are mechanistically 
predisposed to some uncoupling between O2-activation and substrate hydroxylation (12, 
36), and FIH can autohydroxylate in the absence of prime substrate (18), the extent of 
uncoupling during steady-state turnover by FIH is unknown.  Third, release of reactive 
oxygen species (ROS) from the active site should be minimal in order to avoid oxidative 
damage to the cell.  The propensity of FIH to produce ROS has never been tested.   
 
Here we use chemical methods to test the uncoupling and ROS production from human 
FIH in comparison to AtsK, a metabolic αKG hydroxylase involved in bacterial sulfur 
metabolism (37).  As metabolic enzymes are expected to favor fast catalysis over tight 
coupling, we felt that AtsK would be an instructive contrast to FIH. We observed that 
FIH does not uncouple during turnover conditions, nor does it release ROS under any 
tested conditions.  FIH does, however, autohydroxylate in a slow reaction in the absence 
of substrate, forming an inactive form FIH.  In contrast, AtsK uncouples under turnover 
conditions and releases H2O2. 
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2.2 Experimental Procedures 
2.2.1 Materials 
The prime substrate for FIH was a 39-residue peptide corresponding to HIFα788-826 with a 
Cys
800Ala point mutation, which corresponds to the C-terminal transactivation domain 
of HIF-1α (CTAD). The CTAD sequence used (Asn803 underlined) was DESGL-PQLTS-
YDAEV-NAPIQ-GSRNL-LQGEE-LLRAL-DQVN, which was unmodified at the 
peptide termini.  CTAD peptide was purchased from EZBiolabs as a desalted product, 
and was further purified by reverse-phase HPLC. Hexylsulfate (HexSO4) and NADH 
were obtained from Acros Organics. The enzymes used in coupled assays were from 
commercial sources: alcohol dehydrogenase and Cu/Zn superoxide dismutase were from 
MP Biomedicals, horseradish peroxidase was from Fluka. A succinate detection kit was 
purchased from R-Biopharm. 
2.2.2 Protein Expression, Purification and Activity 
AtsK and FIH were expressed and purified as previously described (19, 37). AtsK 
activity was measured continuously with both oxygen sensor using a Clark-type electrode 
and coupling the enzyme reaction with NADH/alcohol dehydrogenase at 25°C.  In O2 
consumption assay, 200 µM ascorbate, 1 mM αKG, 0-1 mM HexSO4 and 100 µM FeSO4 
were premixed in 1 mL volume with 10 mM HEPES pH 7.00, and the reaction was 
initiated by adding 1 µM AtsK, and oxygen consumption was monitored. AtsK activity 
was also monitored by coupling the enzyme reaction with 160 µM NADH and 5 unit/mL 
alcohol dehydrogenase in 100 µL volume by monitoring the absorbance change of 
NADH at 340 nm in UV-Visible(UV-Vis) Spectrometer.  
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FIH activity was monitored by a quenched time point assay and analyzed by LC-MS. In a 
50 µL reaction volume, 2 mM ascorbate, 0.1 mM DTT, 5 unit/mL catalase, 500 µM 
αKG, 25 µM FeSO4, 0-600 µM CTAD were preincubated at 37°C and 0.5-5 µM of FIH 
was added to initiate the reaction. At certain time points 5 µL aliquots were taken and the 
reaction was quenched with 45 µL 0.1% formic acid. For each reaction 5-10 samples 
were prepared on a 3-10 min time scale  and analyzed by LC-MS using a C8 column. The 
+3 charge-state of parental and and hydroxylated CTAD peaks were observed at m/z of 
1419.1 and 1424.4 respectively, as expected for the anticipated mass gain of 16 amu in 
the product. The ratio of hydroxylated CTAD peak intensity to overall peak intensity was 
calculated for each sample and the rate was calculated from a linear fit of these time 
points. 
2.2.3 Uncoupling 
2.2.3.1 Absence of prime substrate 
Small volumes of an AtsK stock (0.38 mM) were injected into a 1.00 mL solution 
containing 100 µM FeSO4, 200 µM ascorbate, 1 mM αKG and were mixed in 10 mM 
HEPES buffer pH 7.00, 25 °C. The FIH assay was performed with 50 µM FeSO4, 500 
µM αKG, and 11.7 µM FIH in 50 mM HEPES, pH 7.50, 37°C. O2 consumption was 
monitored by a Clark-type electrode (YSI Incorporated).  
2.2.3.2 Presence of prime substrate 
The coupling ratio of each enzyme was determined in the presence of varied 
concentrations of primary substrate. For AtsK, the amount of consumed oxygen was 
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compared to the amount of product formed by oxygen consumption and NADH coupled 
assays, respectively. The coupling ratio of FIH was obtained by comparing the amount of 
succinate formed to the amount of hydroxylated peptide. Succinate was measured by UV-
Vis spectroscopy using a succinate detection kit and hydroxylated CTAD was analyzed 
by LC-MS.   
2.2.4 ROS Production 
2.2.4.1 H2O2 / O2
- 
assays 
Hydrogen peroxide production was detected by coupling H2O2 oxidation of  50 M 2,2'-
azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) with 1 Unit/mL horseradish 
peroxidase (HRP). Hydrogen peroxide production was continuously monitored at 405 
nm. Ascorbic acid was excluded from the reaction mixtures to prevent reduction of 
ABTS
+
. Superoxide detection was accomplished in a same manner of peroxide detection, 
by the use of 100 Unit/mL Cu/Zn superoxide dismutase (Cu/Zn SOD) to convert O2
-
 into 
H2O2. The reaction conditions for H2O2 and O2
-
 detection included the coupling reagents 
with the respective enzyme assays; for AtsK: 11.4 M AtsK, 1 mM αKG, 0-100 µM 
HexSO4, 100 µM FeSO4; for FIH: 5 M FIH, 500 M αKG, 50 µM FeSO4, 0-100 µM 
CTAD. 
2.2.4.2 OH• radical assay 
Hydroxyl radical detection of AtsK and FIH was achieved by mixing enzyme activity 
assay solutions with 15 mM 2-deoxyribose (38). Primary substrate concentrations were 
varied for AtsK, 0-600 µM HexSO4; and for FIH, 0-120 µM CTAD. The reactions were 
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initiated by adding enzyme then incubating at 37 °C for 1 hour. Reactions were quenched 
with 100 µl 1% thiobarbituric acid in 50 mM NaOH and 100 µL 2.8 % trichloroacetic 
acid in water. The solution was heated at 100 °C for 20 minutes. After cooling down to 
room temperature, the absorbance at 532 nm was measured. The zero substrate sample 
was treated as a reference.  
2.2.5 Inactivation and Rescue of Inactivated Enzyme 
2.2.5.1 1 Inactivation of AtsK 
Inactivation of AtsK was tested by changing the concentration of AtsK in a reaction from 
1 to 10 µM, in the NADH-coupled assay detected at 340 nm. 1 mM αKG, 1mM HexSO4, 
100 µM Fe(II), 0-2 mM ascorbic acid, 1-10 µM AtsK, 30 µM NADH and 30 units of 
alcohol dehydrogenase were used in a 100 µL reaction volume.  
2.2.5.2 Inactivation and rescue of autohydroxylated FIH 
Autohydroxylated FIH was prepared to test for re-activation conditions. Under anaerobic 
conditions, 50 mM HEPES (pH 7.50) αKG (100 µM), FIH (49 µM) and FeSO4 (50 µM) 
were added to a septum-sealed UV cuvette. An initial UV-Vis absorption spectrum was 
collected; the septum was then removed to introduce air and initiate the reaction. The 
characteristic absorption peak of autohydroxylated FIH (max = 583 nm) grew over 
several hours (18). Autohydroxylated FIH was tested for activity in an assay mixture 
containing αKG (500 µM), FeSO4 (25 µM), CTAD (70 µM), autohydroxylated FIH (5 
µM), and a mild reductant.  The mild reductants ascorbate (0 - 2 mM) and DTT (0 - 0.1 
mM) were tested for their ability to re-activate auto-hydroxylated FIH. Samples were 
analyzed for hydroxylated CTAD by LC-ESI-MS.  
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2.3 Results 
Uncoupling for FIH and AtsK was evaluated by comparing the steady-state kinetic 
signatures of the two half reactions.  As O2 reacts with αKG to form succinate and CO2 in 
the first half-reaction, the stoichiometry of O2-activation was measured by O2 
consumption or succinate formation.  This assumes that O2 is only activated by oxidative 
decarboxylation of KG.  The rate of prime substrate hydroxylation was monitored by 
mass spectrometry for FIH or by a UV-Vis assay for AtsK.  A fully coupled reaction 
would exhibit an [O2]:[hydroxylated product] ratio of unity; deviations from this ratio 
would indicate that O2 was being activated in the absence of substrate hydroxylation. 
 
Uncoupling for AtsK and FIH was measured with variable concentrations of substrate.  
The solution conditions for AtsK included 0 – 1000 µM HexSO4, with up to 3.0 µM 
AtsK.  AtsK was tightly coupled under steady-state conditions, as the number of enzyme 
turnovers was equivalent by both Clark electrode and by the UV-Vis assay.  These assays 
indicated a coupling ratio of 1.04 ± 0.07 in the steady-state for AtsK (Figure 2.1A).  As 
the KM(HexSO4) is 15 µM for AtsK, the measured steady-state coupling ratio for AtsK 
reflected that of an ES complex, indicating that once AtsK bound HexSO4 and entered its 
catalytic cycle it completed the hydroxylation with relatively high fidelity (ca. 96%).  
This indicated that AtsK turnover was much faster than uncoupling from the ES complex.   
 
Similarly, FIH was tightly coupled as shown by the stoichiometry of succinate to 
hydroxylated peptide present in quenched reactions.  FIH (2 µM) was incubated with 
CTAD (200 µM) and the reaction quenched at several time points for analysis. These 
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assays indicated a coupling ratio of 1.03 ± 0.17 in the steady-state for FIH (Figure 2.1B).  
FIH distributed between predominantly an (Fe
2+αKG)FIH form at low [CTAD], and an 
ES complex at high [CTAD], as we measured the KM(CTAD) as 77 µM (39).  Nevertheless, 
FIH exhibited a tightly coupled reaction under steady-state conditions, indicating that O2-
activation by FIH is tightly controlled. It should be noted that the succinate assay used to 
measure O2-activation by FIH was less precise than the simpler UV-Vis assay used for 
AtsK, due to the many reaction components and manipulations needed.   
 
The consumption of O2 by AtsK and FIH in the absence of prime substrate was directly 
monitored by use of a Clark electrode (Figure 2.2).  Small volumes of enzyme (1-3 µL) 
were injected into thermostated 1.00 mL reaction buffer containing FeSO4 (100 µM), 
ascorbate (200 µM), and αKG (1mM).  Despite the tight coupling ratios observed during 
steady-state turnover, O2 consumption was not absolutely tied to substrate hydroxylation 
for either enzyme.  In the case of AtsK, O2 was consumed within 30 seconds at a molar 
stoichiometry of 2.5 (+/- 0.2) O2 per AtsK active site (Figure 2.3).   Such a rapid reaction 
with O2 is reminiscent of the fast inactivation observed for several other αKG 
hydroxylases, such as TauD and TfdA (25, 26).   
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Figure 2.1 Coupling of O2 to prime substrate for AtsK and FIH.  A) O2 consumption vs. 
HexSO4 hydroxylation for AtsK. AtsK (0.38 – 3.0 M), ascorbate (200 M), KG (1 
mM), FeSO4 (100 M), HexSO4 (1 mM), NADH (160 M), alcohol dehydrogenase (5 
Unit/mL) in 10 mM HEPES (10 mM, pH 7.00). B) Succinate production vs. CTAD 
hydroxylation for FIH.  FIH (2.0 M), ascorbate (2000 M), DTT (100 M), KG (500 
M), FeSO4 (50 M), CTAD (240 M) in HEPES (50 mM, pH 7.50).  
 
In contrast, injections of FIH at a final concentration of 11.7 µM consumed no 
measurable O2 on the minutes timescale (Figure 2.2A).  Although we were unable to 
measure any uncoupled O2-consumption for FIH on the minutes timescale, we did 
reproduce the autohydroxylation reaction (18).  Autohydroxylation required O2, and 
formed a hydroxylated Trp
296
 residue on FIH (18), which is formed via hydroxylase 
activity in the absence of CTAD.   
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Although the coupling ratios for both FIH and AtsK were near unity during the steady-
state, the consumption of O2 by AtsK in the absence of prime substrate suggested that 
ROS may be produced by the resting form of AtsK, (Fe+ αKG)AtsK.  As an enzyme will 
partition amongst various forms depending on substrate concentrations, ROS formation 
was measured while varying prime substrate concentrations for both FIH and AtsK.  The 
tested ROS species were superoxide (O2
-
), hydrogen peroxide (H2O2), and hydroxyl 
radical (OH
•
), which may form depending on the number of electrons transferred to O2.   
 
 
Figure 2.2 Oxygen consumption of FIH and AtsK measured with O2 sensor; A) FIH (11.7 
µM) mixed with FeSO4 (50 µM), αKG (500 µM) in 50 mM HEPES pH 7.5 B) AtsK 
(1.14 µM) mixed with ascorbate (200 µM), FeSO4 (100µM), αKG (1 mM) in 10 mM 
HEPES pH 7.00. 
 
Both H2O2 and O2
-
 were assayed by a peroxidase/ABTS assay in which H2O2 was 
indicated by a characteristic absorption at 405 nm due to the formation of ABTS+.  In the 
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absence of HexSO4, AtsK (11.4 µM) produced 0.12 µM H2O2; this was much less than 
the anticipated 2.5 equivalents of O2 consumed by AtsK.  Under steady-state conditions, 
AtsK produced up to 0.47 µM H2O2, with [HexSO4] ranging from 0 – 800 µM.  Notably, 
H2O2 production was a saturable function of [HexSO4], with an apparent half-maximal 
value of 10 µM HexSO4 (Figure 2.4).  As this is similar to the reported KM(HexSO4) (37), it 
suggested that H2O2 was also released from the ES complex of AtsK, 
(Fe
2
+αKG+HexSO4)AtsK.   
 
 
Figure 2.3 Oxygen consumption of AtsK in the absence of HexSO4. AtsK (0.2-1.2 µM) 
mixed with ascorbate (200 µM), FeSO4 (100 µM) and αKG (1 mM) in 10 mM HEPES 
pH 7.00. 
 
 
FIH (5 µM) failed to produce measurable levels of H2O2 under any tested condition.  FIH 
concentrations were varied between 5 and 50 µM in the absence of CTAD to test for 
H2O2 production by (Fe
2++αKG)FIH, however H2O2 was not detected even at 50 µM 
FIH.  FIH was also tested under steady-state conditions with 50 µM CTAD; however, 
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H2O2 was not detected suggesting that the ES complex, (Fe
2
+αKG+CTAD)FIH, did not 
produce H2O2.  This was consistent with the near unity coupling ratio for FIH (Figure 2.4 
inset). 
 
 
 
Figure 2.4 H2O2 produced by AtsK (11.4 µM) during steady state turnover. Inset) 
Timecourse for H2O2 production by AtsK (upper line) and FIH (lower line).  AtsK (11.4  
µM) was added into a reaction mixture containing FeSO4 (100 µM), αKG (1 mM), 
HexSO4 (100 µM), ABTS (50 µM) and HRP (1 unit/mL) in 10 mM HEPES pH 7.00.  
FIH (5 µM) was added into a solution wich has FeSO4 (25 µM), αKG (500 µM), CTAD 
(50 µM), ABTS (50 µM) and HRP (1 unit/mL) in 50 mM HEPES pH 7.50. 
 
 
Superoxide was measured by the use of Cu/Zn SOD to convert two equivalents of O2
-
 
into one equivalent of H2O2 for the peroxidase/ABTS assay.  Neither AtsK nor FIH 
produced detectable O2
-
 by this coupled assay in the absence of prime substrate; 
experiments in the presence of added prime substrate similarly yielded no detectable O2
-
.  
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Hydroxyl radicals were tested by the deoxyribose method, a qualitative colorimetric 
assay that compares OH
•
 production to a baseline condition by normalized absorptivities 
(A/A0); an increase in A/A0 would indicate that more OH
•
 radical were produced.  AtsK 
(1.14 µM) was tested at varied concentrations of HexSO4 (0-600 µM).  This allowed a 
comparison of different enzyme forms, with free enzyme prevalent at sub-saturating 
concentrations of HexSO4, and an ES complex prevalent at saturation.  A plot of the 
normalized data indicated a slight decrease in OH
•
 production in the presence of HexSO4, 
however this was independent of [HexSO4] (A/A0 = 0.91 +/- 0.05) (Figure 2.5A).  This 
showed that OH
•
 radical production was not a function of enzyme form, suggesting that 
neither the free enzyme nor the ES complex produced diffusible OH
•
.  Similarly, FIH (0.5 
µM) was assayed for OH
•
 production at varied CTAD concentrations.  The normalized 
data was a line of zero slope with respect to [CTAD] (A/A0 = 1.03 +/- 0.03) (Figure 
2.5B).  This indicated that OH
•
 radical production was not a function of enzyme form.  
As with AtsK, this suggested that FIH did not produce diffusible OH
•
 radicals. 
 
During steady-state kinetics assays, we noted a biphasic time course for AtsK, indicating 
enzyme inactivation. Inactivation could result from the oxidation of the iron pool into 
Fe(III), or from specific changes to AtsK.  Oxidation of iron was excluded as the reason 
for inactivation by serial injections of AtsK (0.5-1 µM, 1.25-2.5 µL) into a 1.0 mL 
reaction solution containing HexSO4 (1 mM) and FeSO4 (100 µM); ascorbate was 
omitted to simplify data interpretation.  Each injection of AtsK consumed O2 for 
approximately 60 seconds, followed by a return to baseline; subsequent AtsK injections 
were similarly active (Figure 2.6A). This showed that the Fe(II) and HexSO4 in solution 
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were sufficient for turnover, and that diluted AtsK (1 µM) itself became inactive within 
one minute.   
 
Figure 2.5 Hydroxyl radical assays of AtsK and FIH.  A) AtsK (1.14 µM), ascorbate (200 
µM), αKG (1 mM), FeSO4 (100 µM), HexSO4 (0-600 µM), 2-deoxyribose (15 mM) in 10 
mM HEPES pH 7.0 B) FIH (0.5 µM), ascorbate (2 mM), αKG (500 µM), FeSO4 (25 
µM), CTAD (0-120 µM), 2-deoxyribose (15 mM) in 50 mM HEPES pH 7.50.   
 
 
As AtsK is a tetramer (29), we tested de-oligomerization as the cause of the rapid 
inactivation.  Timecourses for varied concentrations of AtsK (0.5 – 10 µM) were 
monitored by either the UV-Vis assay or the O2-consumption assay.  High concentrations 
of AtsK (5 – 10 µM) were active for hundreds of seconds, whereas low concentrations 
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(0.5 – 1 µM) inactivated within 50 seconds (Figure 2.6 A, B), suggesting that de-
oligomerization was the root cause of the rapid inactivation.  
 
 
Figure 2.6 Inactivation of AtsK measured by O2-electrode. A) Sequential injection of 
AtsK (1 µM, 1 µM, 0.5 µM) into a mixture of FeSO4 (100 µM), ascorbate (200 µM), 
αKG (1 mM), HexSO4 (1 mM) in 10 mM HEPES pH 7.00.  B) Injection of high 
concentration of AtsK (7 µM) into same reaction conditions as in A. 
 
FIH exhibited linear progress curves for more than 4 minutes in steady-state assays that 
included ascorbate, indicating that enzyme inactivation was not a rapid process.  
However, we previously observed that FIH would autohydroxylate over several hours to 
form an Fe(III) form of the enzyme called „purple FIH‟ in which Fe(III) was coordinated 
by the hydroxy-group of hydroxylated Trp
296
 (18).  As Saari and Hausinger noted that 
inactivated TfdA was partially rescued by ascorbate (26), we tested two common 
reductants for their ability to rescue auto-hydroxylated FIH.  First, we tested auto-
hydroxylated FIH for activity; purple FIH (5 µM) exhibited no activity following 
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incubation with CTAD (70 µM), FeSO4 (25 µM) and αKG (500 µM), indicating that this 
enzyme form was inactive.  Next, we tested ascorbate (2 mM) and/or DTT (100 µM) for 
their ability to re-activate purple FIH by including these reductants in purple FIH assay 
mixtures, however no activity was observed with these mild reductants (Table 2.1).   
 
 
Table 2.1 Effect of reducing agents on auto-hydroxylated FIH.   
FIH 
(µM) 
Ascorbate 
(mM) 
DTT 
(mM) 
υ 
(µM/min) 
5 (purple) 0 0.1 0.05±0.04 
5 (purple) 2 0.1 0.06±0.05 
5 (purple) 2 0 0.06±0.08 
5 (fresh) 0 0 4.4±0.4 
5 (fresh) 2 0.1 7.3±0.5 
 
2.4 Discussion 
Although the αKG hydroxylases are mechanistically predisposed to uncouple the 
oxidative and reductive parts of their catalytic cycle, the rate and products of uncoupling 
depend greatly on the identity of the enzyme and on reaction conditions.  The reported 
coupling ratio during turnover was within error of unity for all reported examples (20, 26, 
40, 41), indicating that uncoupling occurs on less than ~ 5% of turnovers in the presence 
of prime substrate. However, reactivity toward O2 in the absence of prime substrate is 
variable, as some KG oxygenases release ROS whereas some autohydroxylate, 
suggesting that structural differences may control both the rates and products of 
uncoupling.  Neither FIH nor AtsK were significantly uncoupled during turnover; 
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however they differed in both their reactivity toward O2 in the absence of prime substrate, 
as well as in their uncoupling products.   
 
Coupling between O2-activation and substrate hydroxylation likely relies on three 
structural factors.  The first being local structures which link the binding of prime 
substrate to coordination changes at Fe, such as proposed for hydrogen bonding between 
the facial triad and the Fe-bound H2O (31). In a highly organized active site, the 
(Fe
2++αKG) form of enzyme would be unable to react with O2 until prime substrate 
bound, and would tightly couple O2 activation to substrate oxidation.  The second factor 
is a closed active site to prevent solvent access, such as by loop closure or the binding of 
a large substrate.  The (Fe
2++αKG+Substrate) form of enzyme, the ES complex, would be 
tightly coupled if solvent were unable to reach reactive intermediates, such as (FeO)
2+
. 
The third factor is the presence of oxidizable residues near the active site which may 
react with (FeO)
2+
 or scavenge any generated ROS.  Any ROS formed by O2-activation 
in the absence of prime substrate could then damage the protein rather than diffusing 
away, and has been proposed as a general protective strategy for KG-dependent 
hydroxylases (36). 
 
The free enzyme forms of AtsK and FIH were quite distinct in their propensity to react 
with O2, suggesting differences in their structures.  As described below, the primary 
factor is likely to be hydrogen bonding between the facial triad and the coordinated H2O.  
In the context of the inner-sphere O2-activation model, the Fe(II) in the free enzyme (eg: 
(Fe+αKG)FIH) should be 6-coordinate due to a H2O ligand which is hydrogen bonded to 
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the Asp/Glu ligand.  In order for free enzyme to react with O2, this H2O ligand must be 
released in the absence of prime substrate.  As (Fe+KG)FIH was unreactive toward O2 
on the minutes timescale (Figure 2.2), the H2O-ligand is likely to be tightly bound in FIH.  
In contrast, (Fe
2+αKG)AtsK consumed 2.5 equivalents of O2 (Figure 2.3), suggesting 
weaker hydrogen bonding from the facial triad in AtsK.   
 
While the reactivity data presented herein do not directly probe the strength of this 
hydrogen bond, the structural data for FIH and AtsK are consistent with weakened 
hydrogen bonding in AtsK.  In particular, while Asp
201
 of the facial triad in FIH forms a 
hydrogen bond to the Fe-bound H2O (27), the orientation of AtsK Asp
110
 precludes any 
hydrogen-bond from the facial triad of AtsK (29, 31). The confluence of structural data 
with our reactivity data suggest that hydrogen bonding from the facial triad is a 
significant factor in deactivating FIH towards uncoupled O2-activation.   
 
Differential solvent access to the active sites of FIH and AtsK is unlikely to be the origin 
of the very different uncoupling behavior in the absence of prime substrate, as both active 
sites are highly solvent exposed.  The crystal structures of AtsK suggested that the active 
site would be very solvent accessible, as a „lid‟ formed by residues 80 – 102 was so 
disordered in the crystal structure that it could not be refined (29). This is also consistent 
with the broad substrate tolerance of AtsK, and suggests that solvent access to the active 
site should be facile.  In a similar vein, FIH has no structural obstruction to solvent access 
to the active site in the (Fe+ αKG)FIH enzyme form, as the active site only becomes 
closed upon binding of the prime substrate, CTAD (27). As a consequence, any 
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uncoupled O2-activation in the absence of prime substrate should lead to a highly solvent 
exposed (FeO)
2+
 center in both AtsK and FIH.  That AtsK released ROS, but FIH did not, 
indicated that some combination of slow initial reactivity and internal scavenging (see 
below) is most likely operative in FIH.   
 
The only ROS produced by (Fe+αKG)AtsK was H2O2, suggesting that simple hydrolysis 
of the (FeO)
2+
 intermediate formed H2O2 and regenerated the Fe
2+
 cofactor.  ROS have 
been implicated during uncoupling of KG oxygenases, but seldom observed. Two 
negative examples are enzymes structurally related to AtsK, which also inactivated 
during turnover: TFdA and TauD. The irreversible inactivation of TfdA was suggested to 
involve oxidative damage from hydroxyl radicals, however diffusible OH
•
 was not 
observed (26); neither H2O2 nor O2
-
 were observed during uncoupling by TauD (41). The 
rare positive example is for CS2, which releases H2O2 in the absence of substrate as does 
AtsK (40). A crucial difference between AtsK and CS2 is that unlike CS2, AtsK also 
released H2O2 during normal turnover.  This may relate to the size of the active site 
pocket, as the AtsK active site is highly disordered (29) and may therefore be more prone 
to hydrolytic attack at the FeO
2+
 intermediate than CS2.   
 
The presence of a sacrificial site in FIH may explain the absence of diffusible ROS from 
this enzyme. FIH autohydroxylation led to irreversibly inactivated enzyme on the 
timescale of hours. The autohydroxylated form of FIH, in which the Fe(III) is 
coordinated by the hydroxylated ring of Trp
296
 (18, 19), could not be rescued by the 
addition of common reducing agents nor by excess αKG (Table 2.1).  Irreversible 
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inactivation by „sacrificial‟ reactivity near the active site has precedent in the 
autohydroxylation reactions of TauD, AlkB and TfdA, where new chromophores arise 
from Fe(III) coordination of the newly formed hydroxylated residue, and for which no 
reactivation pathway has been identified (21, 22, 25). We propose that FIH is deactivated 
from aberrant O2 reactivity by strong hydrogen bonding from the facial triad, and further 
insured against ROS release by the internal reaction with Trp
296
.   
2.5 Conclusions 
FIH is a proximate O2-sensor for human cells, controlling vital processes such as basal 
metabolism and angiogenesis.  Understanding the link between O2-activation and 
substrate hydroxylation is crucial to developing therapies targeting FIH function.  Our 
findings show that FIH minimizes uncoupled O2 reactivity at two levels: through an 
inherently low reactivity in the absence of prime substrate; and through presentation of a 
sacrificial acceptor (Trp
296
) near the active site.  The tight control over O2-reactivty for 
FIH is in contrast to the facile production of H2O2 by the bacterial enzyme AtsK, both in 
the presence and absence of the prime substrate for AtsK.  We propose that this low 
reactivity for FIH may be due to strong hydrogen bonding between the coordinated water 
and the facial triad.  Such tight control over O2-activation by FIH is compatible with the 
significance of O2 and O2-derived species to both gene expression and cellular toxicity. 
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2.6 Appendix 
2.6.1 Supplemental 
 
Figure 2.7 AtsK (1.14 µM), ascorbate (200 µM), αKG (1 mM), FeSO4 (0-100 µM), 
HexSO4 (1 mM) in 10 mM Hepes pH 7.00. Reaction was initiated by adding the enzyme 
and oxygen consumption was monitored 
 
Figure 2.8 AtsK (1.14 µM), ascorbate (200 µM), αKG (0-100 µM), FeSO4 (100 µM), 
HexSO4 (1 mM) in 10 mM Hepes pH 7.00. Reaction was initiated by adding the enzyme 
and oxygen consumption was monitored. 
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Figure 2.9 AtsK (1.14 µM), ascorbate (200 µM), αKG (1 mM), FeSO4 (100 µM), 
HexSO4 (0-200 µM) in 10 mM Hepes pH 7.00. Reaction was initiated by adding the 
enzyme and oxygen consumption was monitored 
 
 
Figure 2.10 AtsK (1.14 µM), ascorbate (200 µM), αKG (1 mM), FeSO4 (0-100 µM), 
HexSO4 (1 mM), O2 (0-100%) in 10 mM Hepes pH 7.00. Reaction was initiated by 
adding the enzyme and oxygen consumption was monitored. 
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Table 2.2 Summary of Michaelis-Menten kinetics of AtsK 
 kcat (sec
-1
) Km (µM) Kd (µM) 
Fe(II) 0.41 ± 0.01  12 ± 4 
αKG 0.42 ± 0.03 5.9 ± 1.2  
HexSO4 0.41 ± 0.02 15 ± 2  
O2 0.47 ± 0.03 40 ± 9  
 
2.6.2 Abbreviations 
ABTS, 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);  
KG, alpha-ketoglutarate;  
AtsK, oxygenative alkylsulfatase;  
CS2, clavaminate synthase-2;  
CTAD, C-terminal transactivation domain of HIF;  
ESI-MS, electrospray ionization mass spectrometry;  
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;  
FIH-1, the factor inhibiting HIF;   
HexSO4, hexylsulfate;  
HIF, Hypoxia Inducible Factor;  
HRP, horseradish peroxidase;  
SOD, superoxide dismutase;  
TauD, taurine dioxygenase;  
TfdA, (2, 4-dichlorophenoxy)acetate dioxygenase. 
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CHAPTER 3 
THE SECOND COORDINATION SPHERE OF FIH CONTROLS 
HYDROXYLATION 
3.1 Introduction 
A small number of Fe(II), α-ketoglutarate (KG)-dependent dioxygenases directly 
control cellular oxygen sensing in humans (1-3).  These enzymes hydroxylate specific 
residues within the α-subunit of the hypoxia inducible factor (HIF), thereby affecting the 
transcriptional level of hundreds of genes (4).  The best characterized of these enzymes is 
„factor inhibiting HIF-1‟ (FIH), which hydroxylates the β-carbon of HIF-Asn803 (5); HIF-
Asn
803
 lies within the C-terminal transactivation domain (CTAD) of HIFα.  
Hydroxylating HIF-Asn
803
 turns off HIF-dependent gene expression and is a key step in 
down-regulating angiogenesis.  Understanding the chemical basis of how FIH reacts with 
HIFα and O2 is crucial to understanding tissue O2 homeostasis, and holds potential for 
treating disease states such as cancer or stroke (6-8).  According to the consensus 
chemical mechanism (Scheme 3.1), O2 binds to (Fe
II
+αKG)FIH only after HIFα binds (9, 
10). In this mechanism, the active site Fe(II) of FIH is proposed to change its 
coordination geometry upon binding HIFα, thereby creating a binding site for O2.  A 
close correlation between pO2 and HIF hydroxylation would then result, as the rate would 
be proportional to pO2.  X-ray crystallography of FIH in various substrate-bound states 
revealed a structural linkage between HIF-binding and O2 activation through changes in 
multiple hydrogen-bonding interactions (11-13).  Controlling oxygenation chemistry 
through varied hydrogen bonding to atoms coordinated to the metal has been found in 
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other enzymes and models (14-16), suggesting that the structural changes in FIH might 
also have functional significance.   
 
 
Scheme 3.1 Consensus chemical mechanism 
 
 
The chemistry within the FIH active site occurs at the Fe(II) cofactor, making the 
extended coordination environment of this metal the focus of our investigation.  FIH 
provides a primary coordination sphere of His
199
, Asp
201
, and His
279
, forming a facial 
triad (17), with other coordination sites occupied by H2O or αKG (Figure 3.1).  The 
secondary coordination sphere is comprised of those residues that form hydrogen bonds 
to the ligands.  Spectroscopic and structural data from FIH and related enzymes suggest 
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that coordination changes at Fe are crucial to turnover (9, 18, 19).  Based on evidence 
from related enzymes, these key coordination geometries are proposed to be a six-
coordinate (6C) center for the (Fe
II
+αKG)FIH, and a five-coordinate (5C) center for 
(Fe
II
+αKG+CTAD)FIH. 
 
Figure 3.1 Hydrogen bonding network in the active site of wild type FIH (PDB 1H2K).  
FIH (gray) and CTAD (cyan) shown as strands; hydrogen bond distances (Å), FIH 
residues, and HIF-Asn
803
 are noted.   
 
 
Hydrogen bonds between surrounding residues, substrates, and iron ligands may 
comprise a functionally significant second-coordination sphere for FIH, both for priming 
as well as for oxidative decarboxylation. X-ray crystal structures of FIH imply that the 
single H2O-ligand is lost from the 6C (Fe
II
+αKG)FIH upon binding CTAD, which would 
prime the Fe(II) to react with O2 (11-13). Concomitant alterations in nearby hydrogen 
61 
 
bonds between Arg
238
, Asp
201
, and the H2O ligand suggest that these second-sphere 
interactions may be necessary for priming.  We prepared and characterized the isosteric 
mutant Arg
238Met in order to determine how loss of this hydrogen bond linkage 
affected priming of the Fe(II) to react with O2. 
 
Decarboxylating α-ketoacids generally requires stabilization of negative charge within 
the transition state (18-20).  Notably, a Lys or Arg is positioned as a hydrogen bond 
donor to the C1-carboxylate of αKG in most structures of the αKG dioxygenase 
superfamily (9).  In the case of FIH, Asn
205
 and Asn
294
 appear to fulfill this role via 
hydrogen-bond donation to the C-1 carboxylate.  We prepared and characterized the 
single-point Asn  Ala mutants to test how loss of each hydrogen bond affected O2-
activation in normal turnover as well as autohydroxylation. 
Subsequent to O2-activation, CTAD hydroxylation likely proceeds via a hydrogen 
transfer/rebound steps involving a putative [FeO]
2+
 oxidant observed in related enzymes 
(21, 22).  Precise substrate positioning is necessary to ensure that the putative [FeO]
2+
 
oxidant attacks the proper C-H bond.  The side chain of the HIFα-Asn803 residue is 
located directly above the open coordination site of the Fe(II) in FIH, and forms a 
hydrogen bond pair to FIH-Gln
239
.  This interaction may be crucial for substrate 
positioning, such that the [FeO]
2+
 oxidant reacts selectively with the β-carbon of HIF-
Asn
803
.  Although Gln
239
 is not strictly a second-sphere residue in FIH, the Gln239Asn 
mutant was included in the present study as a way to investigate the role of CTAD 
positioning on catalysis. 
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Testing the functional role of the second-sphere is crucial to understand the intricate 
relationship between the overall structure and function of FIH.  This manuscript reports 
the activity, metal binding, and catalytic precision of second-sphere point mutants of FIH.  
Our results indicate that several second-sphere residues are key to tuning the O2-
reactivity of FIH.    
3.2 Materials and Methods 
3.2.1 Protein expression and purification 
FIH and its mutants were expressed from E. coli with an N-terminal His6 tag and purified 
as previously described (23).  Following purification via Ni-NTA column 
chromatography, the His6 tag was removed by thrombin digestion.  Exogenous metal was 
removed by prolonged incubation with EDTA, and then FIH was further purified by size-
exclusion chromatography to yield the FIH dimer.  
3.2.2 Differential Scanning Calorimetry 
DSC experiments were performed using a MicroCal VP-DSC microcalorimeter (24).  50 
mM Hepes buffer pH 7.50 was used and 50 µM samples were heated in the calorimeter 
over a 25-75 ºC range at a scan rate of 60°C/hour.  A buffer scan was subtracted from 
each dataset to correct for base-line drift. Data analysis was performed using Origin 
Microcal software,(25) the results of which are provided in the supplementary material. 
3.2.3 Metal Binding 
The experimental protocol was modified from Marletta et al. (26). Citrate was used as a 
chelator to buffer the concentration of free Co(II) ion, [Co(H2O)6]
2+
, for which stability 
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constants are reported (27). Co(II) binding to FIH was monitored by fluorescence 
quenching in a deoxygenated solution at room temperature. FIH was present in a 
fluorescence cuvette as a 200 L solution of 1.00 mM sodium citrate, 20 μM FIH, 100 
μM α-ketoglutarate, and 50 mM HEPES pH 7.50. Small volumes of CoCl2 were added 
from a solution of 1.00 mM CoCl2 and 1.00 mM sodium citrate, 50 mM HEPES pH 7.50. 
Following addition of Co(II), the cuvette was gently rocked by hand and the fluorescence 
measured over several minutes until a steady reading was obtained. Samples were excited 
at 280 nm and the fluorescence intensity was measured at 340 nm.  Data fitting and 
results are provided in the supplementary material. 
3.2.4 EPR 
X-band EPR spectra were recorded on a Bruker Elexsys E-500 ESR Spectrometer 
equipped with a Bruker ER 4118CF-O LHe/LN2 cryostat. EPR samples were prepared by 
reconstituting enzymes with CuSO4 in a FIH:Cu
2+
 ratio of 1:0.9; the CuSO4 solution was 
slowly added to the enzyme solution to prevent precipitation. Similarly, FIH(Cu+KG) 
was prepared by adding KG slowly as the final step. Samples totaling 300 L of 1 mM 
enzyme, 0.9 mM CuSO4 and 1 mM KG in 50 mM Hepes, pH 7.50, were frozen in 
quartz tubes with liquid nitrogen. The spectra were obtained by averaging 4 scans at 
9.438 GHz frequency, 20 mW power, 20 G modulation amplitude, 100 GHz modulation 
frequency and a 327 ms time constant. The microwave power was varied to ensure the 
samples were not saturated under reported conditions.  
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3.2.5 UV-Vis Spectroscopy 
Enzyme stocks, FeSO4, and αKG were made anaerobic under an Argon flush. 50 mM 
HEPES pH 7.50 was also made anaerobic by a repeating cycle of vacuum and nitrogen 
flush.  (Fe
II
+KG)FIH spectra were obtained on anaerobic samples containing FIH (250 
µM), FeSO4 (230 µM) and αKG (500 µM) in buffer. Apo FIH spectra were recorded for 
similar samples by omitting KG and FeSO4, and used as background spectra.    
3.2.6 Activity Assays 
Initial rate measurements were performed in 50 mM HEPES pH 7.50 and incubated at 37 
°C in 50 µL reaction volume.  Reaction buffer included 2.00 mM ascorbate, 100 µM 
DTT, 5 unit/mL catalase, 600 µM αKG, 25 µM FeSO4, and 0-600 µM CTAD. The 
reaction was initiated by adding the enzyme (0.5-5 µM), and at certain time points 5 µL 
aliquots were taken and quenched in 45 µL 0.1% formic acid. For each reaction 10 time 
points were collected and quenched, then analyzed by LC-ESI-MS. Samples were first 
loaded onto a C8 column for desalting, and CTAD and hydroxylated CTAD (CTAD
OH
) 
were detected by ESI-MS to determine the mole fraction of peptide that had been 
converted to product, CTAD-OH. Product concentrations were calculated as [CTAD
OH
] = 
(CTAD-OH)  [CTAD]0, and used to determined initial rates, which were then used for 
Michaelis-Menten fits. 
3.2.7 Autohydroxylation 
Autohydroxylation was measured as described previously, with minor changes (28). FIH 
(100 µM), FeSO4 (500 µM), and αKG (500 µM) were anaerobically incubated in 50 mM 
HEPES pH 7.50 for 20 min.  Autohydroxylation was initiated by adding an equal volume 
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of buffer that had been equilibrated under air, and the reaction monitored at 583 nm.  
Competitive autohydroxylation assays included 50 µM CTAD that was pre-incubated 
with the FIH.   
3.2.8 Coupling 
A Hamilton PRP-X300 anion exclusion column and UV detection at 210 nm was used to 
separate and detect succinate yield from quenched steady-state reactions of FIH.  The 
concentration of hydroxylated CTAD, CTAD
OH
, was determined as per the activity 
assays.   The coupling ratio was defined as C = [succinate]/[CTAD
OH
]. 
3.3 Results 
Inspection of the X-ray crystal structure of FIH revealed hydrogen-bonding networks 
surrounding the Fe, which were centered on either αKG or CTAD.  Asn205 and Asn294 
residues donate hydrogen-bonds to the C-1 carboxylate of αKG, suggesting that these 
second-sphere residues may stabilize charge buildup during decarboxylation.  Arg
238
 and 
Gln
239
 make hydrogen bonds with CTAD, suggesting that these residues may position the 
HIF-Asn
803
, or may play a role in priming the Fe for oxygenation chemistry (Figure 3.1). 
The role of these hydrogen bonds was tested by functional assays and electronic 
spectroscopy of point mutants.  
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Table 3.1 Kinetic parameters for WT-FIH and its mutants for KG and the synthetic 
peptide CTAD (39 residues).
a,b
   
 kcat (min
-1
)
a
 KM(KG) (μM)
b KM(CTAD) (μM)
a 
kcat/KM(CTAD) (μM
-1
min
-1
)
a 
WT-FIH 31 ± 4 22 ± 6 77 ± 22 0.41 ± 0.1 
N205A 10.2 ± 0.5 7.5 ± 2 43 ± 8 0.24 ± 0.07 
N294A 2.2 ± 0.1 14 ± 2 137 ± 26 0.016 ± 0.004 
Q239N 0.123 ± 0.002 24 ± 4 38 ± 2 0.0032 ± 0.0002 
R238M
c 
- - - - 
a
 Assays in which CTAD was the varied substrate were performed with FIH and mutants 
(0.5-5 µM), ascorbate (2 mM), DTT (100 µM), catalase (5 unit/mL), αKG (500 µM), 
FeSO4 (25-50 µM), CTAD (0-600 µM) in 50 mM HEPES pH 7.50 at 37 °C.  CTAD 
corresponds to a CysAla point mutant of HIF-1788-826 
b
 Assays in which KG was the varied substrate were as above, with these exceptions: 
CTAD (200 M), and KG varied (3 – 160 M).  
c
 R238M was too slow to assay initial rates. 
 
The effect of hydrogen bonding network on turnover was investigated by steady-state 
kinetics (Table 3.1).  Saturating conditions were determined for ascorbate, αKG and 
Fe(II) and then initial rates of WT-FIH and its mutants were acquired by varying the 
CTAD concentration. DTT and catalase were used in the steady-state assays to prevent 
ferroxidase chemistry by Fe(II) in solution. WT-FIH showed kcat of 31 min
-1
 with a 
kcat/KM(CTAD) of 0.41 µM
-1 
min
-1
, similar to previously reported values (Figure 3.2) (29-
31).  Each of the mutants had a modest effect on KM(CTAD), as both kcat and kcat/KM were 
diminished by a similar factor for each mutant: N205A (3-fold), N294A (15-fold), and 
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Q239N (150-fold) (Figure 3.2 and Figure 3.3). R238M exhibited very low activity, which 
we could only detect through endpoint assays. 
 
Figure 3.2 Steady state kinetics of WT-FIH and N205A. WT-FIH (0.5 µM), N205A (1 
µM), ascorbate (2 mM), DTT (100 µM), catalase (5 unit/mL), αKG (500 µM), FeSO4 (25 
µM), CTAD (0-250 µM) in 50 mM HEPES pH 7.50.   
 
Figure 3.3 Steady-state kinetics of N294A and Q239N. N294A (5 µM), Q239N (5 µM), 
ascorbate (2 mM), DTT (100 µM), catalase (5 unit/mL), αKG (500 µM), FeSO4 (50 µM), 
CTAD (0-600 µM) in 50 mM HEPES pH 7.50.   
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Endpoint assays showed that CTAD-centered mutants were impaired in terms of product 
yield, relative to WT-FIH and the αKG-centered mutants (Table 3.2).  WT-FIH 
hydroxylated 94% of CTAD during prolonged incubations; the αKG-centered mutants, 
N205A and N294A, were nearly as thorough as WT-FIH, converting over 79% of CTAD 
to product.  In contrast, both CTAD-centered mutants were significantly compromised in 
their ability to hydroxylate CTAD, as Q239N and R238M converted less than 25% of 
CTAD to hydroxylated product.   
 
The ratio of succinate production to CTAD hydroxylation was measured, to check for 
coupling between O2-activation and hydroxylation (Table 3.2). As O2-activation produces 
succinate, but might not lead to hydroxylated CTAD, uncoupling between these two 
enzymatic steps would lead to elevated coupling ratios, C = [succinate]/[CTAD
OH
].  WT-
FIH was tightly coupled (43), with C equal to unity within experimental uncertainty (C = 
0.98 ± 0.03).  The Q205A and Q294A point mutants exhibited slightly elevated C values, 
however Q239N exhibited a coupling ratio was appreciably greater than unity (C = 3.1 ± 
0.4).   
 
 
 
 
 
 
 
69 
 
Table 3.2 Coupling and yield of hydroxylated CTAD by FIH variants.
 
 C
a
  % CTAD
OH b
 
WT-FIH 0.98 ± 0.03 94% 
N205A 1.08 ± 0.04 90 
N294A 1.3 ± 0.1 79 
Q239N 3.1 ± 0.4 23 
R238M n.d. 5 
a
 C = [succinate]/[CTAD
OH
] as determined under steady-state turnover conditions; see 
text for details.  Not determined (n.d.). 
b
 Qualitative endpoints: FIH (100M) FeSO4 (500 M), KG (500M), CTAD (50 M) 
50 mM HEPES, pH 7.50. 
 
FIH will slowly activate O2 in the absence of CTAD, autohydroxylating Trp
296
 to form an 
Fe(III)-O-Trp
296
 chromophore with max = 583 nm (23, 28). While the rate-limiting step 
in autohydroxylation is not known, priming of the (Fe
II+αKG)FIH is a likely requirement 
to permit O2-activation.  WT-FIH and the point mutants were tested for 
autohydroxylation rates in the absence of CTAD in order to determine how the priming 
of Fe(II) changed upon mutation.  The autohydroxylation rates for the point mutants were 
only moderately altered from WT-FIH (Table 3.3), suggesting that the second 
coordination sphere had minor effects on steps directly involved in autohydroxylation.  It 
is notable that both KG-centered mutants exhibited 2-fold increases in the 
autohydroxylation rates relative to that for WT-FIH. 
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Table 3.3 Autohydroxylation rates for FIH variants. 
 auto-hydroxylation initial rates (μM/min) 
0 CTAD 50 M CTAD 
WT FIH 0.0442 ± 0.0007 0.0265 ± 0.0008 
N205A 0.100 ± 0.002 0.078 ± 0.001 
N294A 0.0816 ± 0.0008 0.068 ± 0.002 
Q239N 0.034 ± 0.001 0.0564 ± 0.0008 
R238M 0.0262 ± 0.0008 0.0183 ± 0.0013 
100 M FIH, 500 M FeSO4, 500M αKG, 0 or 50 M CTAD, 50 mM HEPES, pH 
7.50.   
 
We felt that a competition assay, in which autohydroxylation was monitored in the 
presence of CTAD, would be an interesting way to further test the effect of second-
sphere mutations on positioning.  In the competition assay, HIF-Asn
803
 and Trp
296
 were 
both present as hydroxylation targets (Table 3.3). The rate of autohydroxylation for WT-
FIH, and most of the point mutants, decreased in the presence of CTAD. The lone 
exception to this was the CTAD-centered mutant Q239N, which underwent 
autohydroxylation 60% faster in the presence of CTAD than in its absence.  This 
increased autohydroxylation rate for Q239N strongly suggested that CTAD binding 
primed Fe(II) to react with O2, but that HIF-Asn
803
 was improperly oriented to receive the 
oxidant in this point mutant.   
 
71 
 
The ability of WT-FIH and its mutants to stabilize negative charge on C-1 of αKG was 
analyzed spectroscopically by the energy of the metal to ligand charge transfer (MLCT) 
transition.  UV-Vis absorption spectra of (Fe
II+αKG)FIH form of each enzyme was 
measured, with the spectrum of the apo enzyme subtracted as a background. Each of the 
(Fe
II
+αKG)FIH samples exhibited an MLCT peak near 500 nm (Figure 3.4). This 
absorption band has been attributed to three overlapping transitions between populated Fe 
T2g(π) orbitals and empty π* orbitals delocalized over the C1 carboxylate and C2 keto 
group of αKG (18). WT-FIH displayed an MLCT maximum at 500 nm, similar to that of 
other αKG hydroxylases such as TauD (530 nm) (32) and CS2 (476 nm) (33).  In αKG-
centered mutants this MLCT was blue shifted (Table 3.4), with the MLCT peaks for 
N205A and N294A appearing at 485 and 490 nm respectively. This blue shift indicated 
that the αKG π* orbitals in these point mutants were destabilized from WT-FIH, 
consistent with the hydrogen-bonds donated by Asn
205
 and Asn
294
 pulling electron 
density away from the keto-group of αKG. 
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Figure 3.4 UV-Vis spectra of (Fe
II+αKG)FIH under anaerobic conditions after 
subtraction of (Fe
II
)FIH spectra. FIH & mutants (250 µM), FeSO4 (230 µM), αKG (250 
µM) in 50 mM HEPES pH 7.50. 
 
 
 
Table 3.4 MLCT transitions in FIH variants.  
max (nm) 
WT FIH 500 
N205A 485 
N294A 490 
Q239N 495 
R238M 488 
FIH (250 µM), FeSO4 (230 µM), αKG (250 µM) in 50 mM HEPES pH 7.50. 
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Substrate centered mutations also showed blue-shifted MLCT bands (Table 3.4). Charge 
transfer complexes of Q239N and R238M appeared at 495 and 488 nm respectively. The 
slight shift in the MLCT energy for Q239N is consistent with the short distance between 
residue 239 and αKG, suggesting only minor structural perturbations.  The larger shift 
observed for R238M is similar in magnitude to that observed for N294A, and may be 
tentatively attributed to polarization effects from the loss of the positive charge at residue 
238.   
 
Cu(II) was used as a spectroscopic probe for the electronic fine structure in FIH. EPR 
spectra of both (Cu)FIH and (Cu+αKG)FIH were measured for WT-FIH and each point 
mutant (Table 3.5).  The spectra of the point mutants were similar to that of WT-FIH, 
with some heterogeneity evident in the (Cu)FIH samples that diminished significantly in 
the (Cu+αKG)FIH samples.  As FIH only provided three protein derived ligands, 
heterogeneity in the (Cu)FIH samples likely arose due to the presence of two or three 
solvent-derived ligands with variable bond lengths to the Cu(II). The WT (Cu)FIH 
sample exhibited an axial spectrum with apparent geff and A|| values (g = 2.06; g|| = 2.3; 
A|| = 148.1 G) appropriate for a “Type 2” Cu(II) site with mixed N and O-donor ligands 
(Figure 3.5) (34).  Spectra of the WT (Cu+KG)FIH sample exhibited increased 
anisotropy in geff (g = 2.06, g|| = 2.35) and reduced hyperfine coupling (A|| = 136.4 G) as 
compared to (Cu)FIH (Figure 3.6).  The small A|| is similar to that reported for other αKG 
hydroxylases (35-37), where it was attributed to an O-rich anionic ligand set and distorted 
planarity (37).  The spectra for the (Cu+αKG)FIH point mutants were nearly identical to 
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those of WT-FIH, showing that the point mutations did not alter the metal coordination 
geometry in the (Cu+KG)FIH enzyme form.  
 
 
Table 3.5 EPR spectral parameters for (Cu)FIH and (Cu+αKG)FIH.  
 EPR parameters 
g|| g A|| (G) 
(Cu)FIH 2.30 2.06 146.2  
(Cu)N205A 2.31 2.06 131.0 
(Cu)N294A 2.31 2.06 134.6 
(Cu)Q239N 2.29 2.06 135.0 
(Cu)R238M 2.31 2.06 144.8 
(Cu+αKG)FIH 2.35 2.06 136.4  
(Cu+αKG)N205A 2.35 2.06 136.4 
(Cu+αKG)N294A 2.35 2.07 136.4 
(Cu+αKG)Q239N 2.35 2.07 136.8 
(Cu+αKG)R238M 2.35 2.07 136.1 
Parameters observed using Spincount(44) 
 
 
 
75 
 
Global enzyme stability was not altered by point mutation, as shown by the irreversible 
melting temperatures (TM(app)) determined by DSC (Table 3.).  The TM(app) of wild type 
FIH was 54.5 °C, whereas the TM(app) for the mutants were, in fact, slightly higher.  
Substrate centered mutants R238M and Q239N had slightly higher TM(app) than wild type, 
56.2 and 56.7 °C respectively. The TM(app) of αKG centered mutants N205A and N294A 
were 58.6 and 58.9 °C respectively, again indicating that the second sphere mutations did 
not alter overall protein stability.   
 
 
Figure 3.5 X-band EPR spectra of (Cu
II
)FIH variants. FIH and point mutants (1 mM), 
CuSO4 (0.9 mM) in 50 mM HEPES pH 7.50.  9.438 GHz, 20 mW power, 20 G 
modulation amplitude, 100 GHz modulation frequency, 327 ms time constant, 77 K. 
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The metal binding of FIH was slightly affected by point mutation, as shown by the Co(II) 
titrations (Table 3.).  The equilibrium dissociation constant for (Co
2+
+KG)FIH was 
1.38(6)  10-7, indicating a relatively strong affinity for Co2+.  Each of the point mutants 
exhibited a similar dissociation constant, with KD ranging from 1.0 – 1.9  10
-7
.  This 
indicated that the primary coordination sphere of the active site was not altered by 
mutagenesis in the secondary sphere.   
 
 
Figure 3.6 X-band EPR spectra of (Cu
II+αKG)FIH variants. FIH and mutants (1 mM), 
CuSO4 (0.9 mM), αKG (1 mM) in 50 mM HEPES pH 7.50. 9.438 GHz frequency, 20 
mW power, 20G modulation amplitude, 100 GHz modulation frequency, 327 ms time 
constant at 77 K. 
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3.4 Discussion 
Hydrogen bonding networks have been shown to be crucial to the function of enzymes 
reacting with O2-derived species, such as lipoxygenase and SOD (15, 16), as well as for 
O2-activating models (14).  In the case of FIH, hydrogen bonding was observed between 
the facial triad ligands of Fe(II), the KG, and various second-sphere residues, 
suggesting a functional role in tuning the chemistry of the Fe(II) center.  In addition 
Gln
239
 hydrogen bonds to the CTAD substrate, and its role in substrate positioning has 
been included. The present work combines kinetics and spectroscopy to show that these 
second sphere hydrogen bonds play roles in promoting oxidative decarboxylation, 
priming Fe(II) to bind O2, and positioning HIF-Asn
803
.   
 
The steady-state rate constants, kcat and kcat/KM(CTAD), were diminished for each point 
mutant of FIH (Table 3.1), indicating a reduction in the rate of one or more steps during 
turnover.  These rate constants can be interpreted within the context of an ordered 
sequential mechanism, which is the consensus chemical mechanism for αKG 
hydroxylases (9, 10).  A minimal kinetic model (Scheme 3.2) for FIH in the presence of 
saturating αKG involves separate microscopic steps for binding S = CTAD (k1) and O2 
(k2), with an irreversible chemical step (k3) followed by product release (k4).   
 
Scheme 3.2 Minimal kinetic model for FIH 
 
The steady-state rate constants are composites of the above microscopic steps.  All steps 
after substrate binding contribute to kcat, while kcat/KM(CTAD) is a function of all steps up 
through the first irreversible step.  The reduced values to both kcat and kcat/KM(CTAD) for 
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each point mutant suggests that the second coordination sphere plays a significant role in 
determining k3, the common microscopic step.  This first irreversible step may be 
oxidative decarboxylation of αKG to form the [FeO]2+ intermediate, as seen for TauD 
(38, 39), or a another step forming an Fe(II) center, as implied for PHD (40).  In the 
absence of additional mechanistic probes such as kinetic isotope effects, we turned to the 
use of electronic spectroscopy and inactivation kinetics to test the effect of the second 
sphere residues.   
 
Point mutations to second sphere residues were non-perturbing to the protein structure 
and primary coordination of the metal center in mutated FIH, as shown by the 
thermodynamic stability and electronic spectroscopy of each mutant.  EPR spectra of the 
point mutants showed that the metal center in (Cu+αKG)FIH retained a virtually identical 
ground-state electronic environment to WT-FIH (Figure 3.6).  The MLCT transitions for 
(Fe
II+αKG)FIH variants revealed that the αKG was a bidentate ligand to Fe(II), while 
also providing a view of the changing Lewis acidity of the C2-position of αKG (Figure 
3.4).  As nucleophilic attack of superoxide at C2 is thought to be a key step in O2-
activation by KG-dependent oxygenases (41), the Lewis acidity of the keto group is 
essential for oxidative decarboxylation.  The blue shifts in the MLCT energies for point 
mutants indicated that the αKG π* orbitals were destabilized in the N294A and N205A 
mutants, suggesting that the hydrogen bonds found in WT-FIH serve to pull electron 
density away from the C2 position of KG.     
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Oxidative decarboxylation is promoted by stabilizing negative charge buildup in the 
transition state, as shown for enzymes (20) and model complexes (41). Structural analysis 
and the MLCT shifts in FIH indicate that both Asn
205
 and Asn
294
 pull electron density 
away from KG, although the Fe(II) likely plays the predominant role in activating KG 
for decarboxylation. Asn
294
 plays a more significant role than Asn
205
 in stabilizing 
charge, as shown by the relative values for kcat: WT > N205A > N294A (Table 3.1). This 
may be due to Asn
294
 being the sole residue pulling electron density away from the distal 
O of the C1 carboxylate of αKG, while both Asn205 and Fe(II) pull electron density from 
the proximal O of the C1 carboxylate (Figure 3.1).     
 
The significant decrease in the steady-state rate constants for CTAD-centered mutants 
may arise from changes in Fe(II) priming or CTAD positioning.  The consensus chemical 
mechanism suggests that mutations affecting priming should principally reduce 
kcat/KM(CTAD), as steps up through O2-activation determine this rate constant.  Conversely, 
mutations affecting positioning should reduce kcat, as steps following O2-binding 
determine this rate constant.  Although the structure of FIH with CTAD bound suggests 
that there may be hydrogen bonds with specific roles, such as those between Gln
239
 and 
HIF-Asn
803
 (positioning), and Arg
238
 and Asp
201
 (priming), the kinetics data is less clear 
as each point mutation reduced kcat as well as kcat/KM(CTAD) when compared to WT FIH.  
This may arise from an effect on a chemical step common to both rate constants, such as 
O2-activation, or from the extended hydrogen bond network linking Asp
201
 to HIF-Asn
803
 
thorugh Arg
238
 and Gln
239
 (Figure 3.1). It appears that positioning the sidechain of HIF-
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Asn
803
 is integral to the priming of Fe(II), and may even be a design feature to ensure 
tight coupling between O2-activation and substrate hydroxylation.   
 
While priming could not be separated from substrate positioning by steady-state kinetics, 
the two roles could be distinguished by the coupling ratio, and by analysis of 
hydroxylation products, as shown for TauD (42).  A functional view of priming is the 
abilty of FIH to activate O2 only once CTAD binds, leading to close coupling between 
the production of succinate and CTAD
OH
.  In the case of WT-FIH, breakdown in priming 
leads solely to autohydroxylation as FIH does not release reactive oxygen species (23, 28, 
43).  This was supported by our observation of a coupling value of unity (C = 0.98 ± 
0.03) for WT-FIH, and a near-unity coupling ratio for N205A and N294A.   
 
Positioning HIF-Asn
803
 in the proper registry within the active site is crucial to ensure 
that the [FeO]
2+
 oxidant attacks the correct residue and forms the CTAD
OH
 product.  The 
Q239N mutant exhibited notable effects on the coupling ratio, indicating that Gln
239
 was 
crucial for local positioning ( 
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Table 3.2).  Q239N was the only mutant in which the coupling ratio differed significantly 
from unity (3.1 ± 0.4), and the only mutant that autohydroxylated faster in the presence of 
CTAD.  These observations indicate that, while Q239N was able to activate O2, the HIF-
Asn
803
 sidechain was improperly positioned to form normal product.   
 
FIH serves a crucial role in sensing hypoxia within human cells.  As an O2-sensing 
enzyme, it must maintain tight coupling between O2-activation and substrate 
hydroxylation, which it achieves by hydrogen bonding between ligands to the Fe and the 
second coordination sphere.     These second sphere hydrogen bonds play roles in 
promoting O2-activation as well as maintaining the structural registry between CTAD and 
Fe.  Hydrogen bonds from Asn
205
 and Asn
294
 pulled electron density away from KG, as 
shown by the LMCT transitions; removal of either hydrogen bond in the AsnAla point 
mutants slightly accelerated autohydroxylation, but made normal turnover much slower 
in the case of Asn
294Ala.  It is likely that autohydroxylation rates reflect the intrinsic 
reactivity of KG, whereas the rate of normal turnover is more dependent on precise 
positioning of CTAD.  For this reason, the rate constants for normal turnover are greatly 
reduced in Gln
239Asn and Arg238Met, both CTAD-centered mutants.  By virtue of 
their respective locations relative to Asp
201
 and HIF-Asn
803
, it is likely that Arg
238
 is 
necessary for priming of the Fe(II) in response to CTAD binding, whereas Gln
239
 is more 
involved in positioning HIF-Asn
803
.  The second sphere interactions play a significant 
role in O2-sensing function of FIH by tuning the chemistry at the Fe(II) center.   
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3.5 Appendix 
3.5.1 Supplemental 
3.5.1.1 Thermal stability of FIH variants 
The thermal stability of FIH variants was measured by differential scanning calorimetry, 
as described in the text. 
Table 3.5 DSC melting temperature analysis of FIH and its mutants.   
 TM(app) (°C) 
WTFIH 54.5 
N205A 58.6 
N294A 58.9 
R238M 56.7 
Q239N 56.2 
FIH (50 µM) in 50 mM HEPES pH 7.50, temperature range: 25-75 °C, scan rate: 60 
°C/hour.   
3.5.1.2 CoII Binding thermodynamics to FIH variants 
3.5.1.2.1 Metal titration data fitting 
 
The binding affinity of (Co
2++αKG)FIH for Co2+ was obtained by competitive titration in 
50 mM HEPES, pH 7.50 at 23ºC.  A 200 μL solution of apo FIH (20 μM), citrate (1.00 
mM), and αKG (100 μM) was temperature equilibrated in a fluorescence cuvette, while a 
separate solution of CoCl2 (1.00 mM) with citrate (1.00 mM) in buffer was loaded into a 
titrating syringe.  As FIH-1 utilizes αKG as a co-substrate as well as a bidentate ligand 
for metal, αKG was included to complete the relevant ligand set of (Co2++αKG)FIH.  
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This experiment used citrate to buffer the concentration of free Co
2+
, or Co(H2O)6
2+
, as 
the log β values for Co(II) binding to citrate are well defined (1). Upon addition of small 
volumes of CoCl2, apo FIH bound the available αKG and Co
2+
. The fluorescence 
intensity of FIH-1 at 340 nm (F340) was plotted against log[Co
2+
]free, exhibiting the 
sigmoidal shape characteristic of a binding equilibrium.  The binding curve was fitted to 
a simple 1:1 binding equilibrium in which the Co
2+
 dissociation constant of 
(Co
2++αKG)FIH (KD) is with respect to Co(H2O)6
2+
 (Eq. S1). The fluorescence intensity 
(F340) was fitted to Eq. S2 (2) which yielded log KD  (x) relative to the log[Co
2+
]free  (c), 
using a cooperativity parameter (B) which accounted for both chemical cooperativity 
involved with dimeric FIH-1 as well as the spectroscopic cooperativity involved with 
fluorescence signal from the eight Trp residues of FIH. The results are in Table 3.. 
(S2)             )101/()(
(S1)     apoFIH)OCo(HFIH)αKGCo(
)(
minmaxmin340
2
62
2
BxcFFFF 



 
Table 3.6 Co
II
 binding affinity of FIH-1 mutants in the presence of αKG 
 KD (M)  B 
WTFIH 1.38(6)x10
-7
 2.2 ± 0.2 
N205A 1.63(3) x10
-7
 1.6 ± 0.1 
N294A 1.01(4) x10
-7
 2.3 ± 0.2 
R238M 1.45(8) x10
-7
 1.9 ± 0.2 
Q239N 1.9(2) x10
-7
 1.3 ± 0.1 
CoCl2 (1 mM) / citrate (1 mM) was titrated into FIH (20 µM), αKG (100 µM) in 50 mM 
HEPES pH 7.50.   
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3.5.1.2.2 References:  
 
1. Martell, A. E., and Smith, R. M. (eds). (1974) Critical stability constants, Plenum  
Press,  New York 
 
2. Mills, S. A., and Marletta, M. A. (2005) Biochemistry 44, 13553-13559 
3.5.2 Abbreviations 
KG, alpha-ketoglutarate;  
CTAD, C-terminal transactivation domain of HIF;  
DSC, differential scanning calorimetry;  
EPR, electron paramagnetic resonance;  
FIH, factor inhibiting HIF-1;  
HIF, hypoxia inducible factor;  
LC-ESI-MS, liquid chromatography – electrospray ionization mass spectrometry;  
MLCT, metal-to-ligand charge transfer;  
NTA, nitrilotriacetate;  
SOD, superoxide dismutase 
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CHAPTER 4 
SOLVENT ISOTOPE EFFECTS ON FIH 
4.1 Introduction 
Solvent isotope effects (SIE) can be seen when enzymatic rates are measured in H2O, 
D2O or mixture of these solvents. Solvent isotope effects are more global when compared 
to substrate isotope effects which use one or few isotopic positions. Because the physical 
properties of D2O are different, replacing H2O with D2O might affect the enzyme 
stability, conformational change, substrate binding and kinetic & equilibrium constants 
associated with enzymatic reactions. Overall change is termed as solvent isotope effects 
which is expressed as ratios of the rate constants in two solvents (1, 2). When the kinetic 
parameters kH/kD, VH/VD or (V/K)H/(V/K)D are larger than unity (larger in H2O) a normal 
solvent isotope effect is observed. When the parameters are less than unity (larger in 
D2O), it is called an inverse solvent isotope effect.  
 
Acid dissociation constant for H2O (1x10
-14
) is about ten times larger than that of D2O 
(1x10
-15
). While the pH of H2O is 7.00, pD of D2O is 7.41 which is a significant isotope 
effect and might have important consequences on pH and pD sensitive rate constants. 
Generally pD values are corrected by a factor of 0.4 (pD=pH+0.4) and thus accurate 
measurements of pH and pD are required for sensitive solvent isotope effects (3-6).  
 
If the enzyme structure /function is maintained by hydrogen bonding network, 
conformation and stability can change in heavy water. Because the intermolecular 
hydrogen bond length is longer in D2O, conformation and stability can slightly alter in 
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heavy water (7). So the overall structure might not be perturbed but loss of activity is 
possible due to instability of protein in heavy water. If substrate binding is pH sensitive 
or causes a conformational change, solvent isotope effect would be expected. SIE on 
microscopic rate constants of enzyme catalyzed reactions would affect steady-state 
parameters kcat and kcat/KM. The best way to determine SIE on kcat and kcat/KM is to 
measure them as a function of substrate. If pH profile of an enzyme is considered in 
which the enzyme rate follows a bell shaped curve, monitoring the effects of SIE at one 
pH and one pD will not be enough. When the steady-state parameters of an enzyme do 
not change over a couple of pH/pD units, the most stable pH region can be chosen and 
the SIE studies can be done at that pH range. Otherwise wide range of pH range should 
be selected because SIE requires sensitive measurements. 
  
Scheme 4.1 Steps of FIH between the resting state and substrate binding which might 
show solvent isotope effect. 
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SIE measurements in a wide pH range would also give information about the ionization 
states of enzyme and/or substrate. Substrate binding, enzyme/substrate ionization state 
and/or product release might all show solvent isotope effects if those steps are pH or 
solvent dependent. 
 
Examples of solvent isotope studies on nonheme iron enzymes showed no significant 
effects. An ethylene forming enzyme ACCO showed only background SIE (8) and TauD 
did not show any SIE (9). Although there is no significant SIE among these enzymes, 
FIH will be tested for any solvent isotope effects.  
 
In the case of FIH, water release upon CTAD binding is the most interesting step because 
iron center needs to be five-coordinate for binding and activation of oxygen (Scheme 
4.1). If the rate determining step is the water release upon CTAD binding, changing H2O 
with D2O might show a solvent isotope effect. Properties of normal and heavy water are 
different in the following ways: First, OH intramolecular bond length is longer than OD 
by about 0.03 Å or 3%. Second, intermolecular hydrogen bonding distance in H2O is 
shorter than in D2O by 0.07 Å or 4%. Also the distance between hydrogen atoms on 
neighboring molecules is about 2% longer for H2O than in D2O. Finally, the number of 
hydrogen bonds per water molecule is less in H2O than in D2O (3.62 vs. 3.76). So there is 
an overall change geometrically (7).  
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If these geometrical differences are applied, hydrogen bonds are stronger in D2O which 
results in higher density, viscosity and boiling point (3). Zero-point vibrational energy of 
water molecules are decreased when they are deuterated.  In terms of energy, D2O 
exchange from the Fe(II) center should be slower which would cause normal solvent 
isotope effects. However, when the hydrogen bonding property of D2O is taken into 
account, it might exchange faster than normal water. Stronger hydrogen bonding in D2O 
can weaken Fe-D2O bond causing a faster exchange and slower isotope effect (inverse 
SIE) with a higher kcat but no change in Km. If this step is not the rate limiting step, SIE=1 
would be expected.  
 
Substrate binding might also be affected by heavy water. Because CTAD is a pretty large 
substrate, hydrogen bonding interactions between CTAD and FIH would change upon 
changing H2O with D2O. Because D2O forms stronger hydrogen bonds, the interaction 
between FIH and CTAD would be more pronounced.  To test this mechanism, one pH/pD 
point will not be enough to compare because a solvent isotope effect seen might not be 
only due to substrate binding step. Interpretation of SIE is generally hard so in addition to 
wide pH profile control experiments should be done.  
4.2 Materials and Methods 
4.2.1 Activity assays and pH profile 
Initial rate measurements were performed in 50 mM HEPES (pH 6.50, 6.90, 7.40 and 
7.80) and incubated at 37 °C in 50 µL reaction volume.  Reaction buffer included 2.00 
mM ascorbate, 500 µM αKG, 25 µM FeSO4, and 0-300 µM CTAD. The reaction was 
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initiated by adding the enzyme (0.5 µM), and at certain time points 5 µL aliquots were 
taken and quenched in 45 µL 0.1% formic acid. For each reaction 10 time points were 
collected and quenched, then analyzed by LC-ESI-MS. Samples were first loaded onto a 
C8 column for desalting, and CTAD and hydroxylated CTAD (CTAD
OH
) were detected 
by ESI-MS to determine the mole fraction of peptide that had been converted to product, 
CTAD-OH. Product concentrations were calculated as [CTAD
OH
] = (CTAD-OH)  [CTAD]0, 
and used to determine initial rates, which were then used for Michaelis-Menten fits. The 
steady-state parameter kcat vs. pH was fitted to equation 4.1 to obtain a kinetic pKa value 
of FIH.   
pKapH
pKapH
cat
enzenzH
k





1010
10*10*
       Eq. 4.1 
4.2.2 Solvent isotope effects 
For solvent isotope effect studies, MALDI was chosen over LC-ESI-MS. Because in ESI-
MS, +3 charge states caused misinterpretation of data. During the HPLC run, deuterated 
samples were back exchanged to some extent. CTAD and CTAD
OH
 m/z appeared in two 
places due to H2O and D2O and this has led the data being not useful. To avoid these 
problems SIE measurements were performed like in the previous part by using MALDI 
with the following changes. Reaction buffer (50 mM Hepes pH 7.0) included 2.00 mM 
ascorbate, 500 µM αKG, 25 µM FeSO4, and 0-200 µM CTAD. The reaction was initiated 
by adding the enzyme (0.5 µM), and at certain time points 5 µL aliquots were taken and 
quenched in 5-15 µL freshly prepared saturated sinapinic acid solution in 75% 
ACN+0.2% TFA (in H2O).  For the measurements in D2O, buffer solution of 50 mM 
Hepes pD 7.0 was prepared by dissolving Hepes salt in D2O and adjusting the pH by 
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NaOH to 6.60 (pD was corrected by adding 0.4 to pH reading). The reaction buffer (50 
mM Hepes pD 7.0) included 2.00 mM ascorbate, 500 µM αKG, 25 µM FeSO4, and 0-200 
µM CTAD (all reagents were prepared in D2O, CTAD was in 50 mM Hepes pD 7.0 
buffer). The reaction was initiated by adding the enzyme (0.5 µM in 50 mM Hepes pH 
7.0), and at certain time points 5 µL aliquots were taken and quenched in 5-15 µL freshly 
prepared saturated sinapinic acid solution in 75% ACN+0.2% TFA (in D2O). Based on 
the volume percentages, the deuterium content was calculated to be around 90% for SIE 
measurements. Measurements were done in triplicate.  
 
The matrix quenched samples were then spotted on the target and analyzed by two 
different MALDI (Bruker Daltonics Omniflex III MALDI TOF and Autoflex III MALDI 
TOF) mass spectrometers. Omniflex and Autoflex are low and high resolution 
instruments respectively. The tuning parameters for both instruments were as the 
following;  
 Omniflex Autoflex 
Ion Source 1 19 kV 19 kV 
Ion Source 2 17.30 kV 17.30 kV 
Lens 9.4 kV 9.4 kV 
Reflector 0 kV 20 kV 
Detector Mode Linear  Reflective  
Shots 1000 1000 
 
Analysis of the data was done by taking the ratios of hydroxylated CTAD intensity to 
overall intensity to determine concentration as it was done in the previous part. 
Calculated and observed masses of CTAD in H2O and D2O are summarized in Table 4.1.   
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Table 4.1 Calculated and observed CTAD mass in H2O and D2O   
Sequence Backbone 
Fast 
exchan
gable 
Sum 
Mono 
mass 
Avg mass 
Back 
bone 
deuterate
d mass 
Fully 
deuterat
ed mass 
Observ
ed 
mass in 
H2O 
 
Observ
ed 
mass in 
D2O 
 
DESGL
PQLTS
YDAEV
NAPIQ
GSRNL
LQGEE
LLRAL
DQVN 
36 38 74 4252.13 4254.58 4290.81 4329.04 4255 4326 
The residues that have fast exchangeable protons: STYCDEHWKQNR 
4.3 Results and Discussion 
Obtaining a wide pH profile for an enzyme is generally hard due to the limitations of 
buffer capacities. Two or three component buffers can be used to make the buffer work in 
a wider pH range. In this case ionic strength should be controlled. Because all of the 
previous studies have been done in 50 mM Hepes, we have chosen to stay in Hepes 
within its buffer capacity (useful pH range for Hepes is 6.8-8.2). 50 mM Hepes pH 6.50, 
6.90, 7.40 and 7.80 buffers were prepared by dissolving Hepes salt in water and adjusting 
the pH by NaOH to the according values. The lowest pH point was little off the buffer 
capacity but at the end of each initial assay the final pH values were checked to make 
sure reaction is occurred at that pH. The Michaelis-Menten fits can be seen in Figure 4.1.   
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Figure 4.1 Michaelis-Menten fits of FIH at different pHs. FIH(0.5 µM), αKG(500 µM), 
Ascorbate (2 mM), Fe (25 µM), CTAD (0-300 µM) were mixed in 50 mM Hepes 6.5, 
6.9, 7.4 and 7.8 buffers. 
 
When the steady-state parameters kcat and kcat/KM were plotted as a function of pH, no 
drastic change is observed (Figure 4.2 and Figure 4.3). This small pH range did not give a 
kinetic pKa so we chose to work around pH 7.0. Log-log plots of kcat vs. pH was almost 
linear. 
 
Table 4.2 Steady-state parameters of FIH at different pHs. 
 kcat, min
-1 
Kcat/KM, µM
-1
min
-1 
pH 6.5 41.3 ± 4.2 0.52 ± 0.15 
pH 6.9 37.7 ± 3.2 0.57 ± 0.14 
pH 7.4 31 ± 2 0.65 ± 0.15 
pH 7.8 29 ± 2 0.92 ± 0.23 
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Figure 4.2 log(kcat) vs. pH. FIH showed no pKa over pH 6.4-7.8 range. 
 
 
 
 
 
Figure 4.3 kcat/KM of FIH in pH 6-4-7.8 range. 
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The steady-state parameters and fitting parameters were summarized in Table 4.2. For the 
solvent isotope effect studies pH 7.0 was chosen because kcat/KM does not change around 
that pH value. If the kcat/KM value deviates within small pH range, that would cause 
insensitive SIE measurements. If any SIE was to be observed, that might be due to pH 
changes. So kcat/KM should not change drastically within a small region for the control 
experiments. After preparing 50 mM Hepes pH/pD 7.0 initial assays were done according 
to the protocol mentioned in methods.  H2O data showed a similar Michaelis-Menten 
curve with the data in pH profile studies. FIH has a kcat of 34.1±1.8 min
-1
 and Km value of 
88.2±10.9 µM in 50 mM Hepes pH 7.0 (Figure 4.4). However the D2O data behaved 
differently so Michaelis-Menten type kinetics was not observed Figure 4.4. Up to 50 µM 
CTAD concentration reaction is faster in D2O than in H2O. When the CTAD 
concentration was increased, a proinhibition type behaviour was observed. Because there 
is not any inhibitior in the reaction mixture, CTAD itself inhibited FIH. This type of 
behaviour due to heavy water could not be addressed; a proinhibition kinetics model 
(equation 4.2) was used to obtain Ki value for CTAD. The steady-state parameters are 
summarized in Table 4.3.  
4.2 Eq.                     
][
][
1
i
m
cat
K
S
S
K
k
E
V


 
Omniflex MALDI instrument gave low resolution spectra in which CTAD and 
hydroxylated CTAD peaks were not separated enough. The data was still useful to obtain 
initial rates but to make things sure, SIE measurements were repeated with a high 
resolution Autoflex MALDI. The comparison of low and high resolution instruments can 
be seen in Figure 4.5. Interestingly Autoflex MALDI gave the same results. So the 
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inhibition behaviour seen is not due to resolving issues at high CTAD concentrations. SIE 
measurements were repeated several times in both high and low resolution instruments, 
in all of which a proinhibition can be observed (Figure 4.6). To address this proinhibiton 
behaviour, all of the reagents were prepared fresh several times including the buffer. 
CTAD is also purified, lyophilized and dissolved in pD 7.0 buffer but the results were 
same.   
 
 
Figure 4.4 Solvent Isotope Effects on FIH. H2O data (■); FIH(0.5 µM), αKG(500 µM), 
Ascorbate (2 mM), Fe (25 µM), CTAD (0-250 µM) were mixed in 50 mM Hepes pH 7. 
D2O data (●);  FIH(0.5 µM), αKG(500 µM), Ascorbate (2 mM), Fe (25 µM), CTAD (0-
250 µM) were mixed in 50 mM Hepes pD 7. αKG, Ascorbate and Fe(II) solution were 
prepared in D2O, CTAD was in 50 mM Hepes pD 7 buffer and FIH was in 50 mM Hepes 
pH 7 buffer. D2O content is 90%. 
 
 
Table 4.3 Steady-state parameters of FIH in pH 7.0 and pD 7.0. 
 kcat Km Ki 
pH 7.0 34.1 ± 1.8 88.2 ± 10.9  
pD 7.0 92.3 ± 34.8 37.1 ± 21.6 29.3 ± 13.9 
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Figure 4.5 Comparison of low resolution and high resolution MALDI instruments. CTAD 
m/z is 4326 and CTAD-OH m/z is 4342 in D2O 
 
 
 
Figure 4.6 FIH(0.5 µM), αKG(500 µM), Ascorbate (2 mM), Fe (25 µM), CTAD (0-250 
µM) were mixed in 50 mM Hepes pD 7. αKG, Ascorbate and Fe(II) solution were 
prepared in D2O, CTAD was in 50 mM Hepes pD 7 buffer and FIH was in 50 mM Hepes 
pH 7 buffer. D2O content is 90%.  Autoflex is high resolution MALDI, Omniflex is low 
resolution MALDI.  
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4.4 Conclusions and Future Directions 
These studies could not be completed due to time limitation. If the substrate inhibition at 
high concentrations could be addressed, FIH might still show faster rates in heavy water 
which means an inverse solvent isotope effect. SIE measurements in a wider pH range 
would also give better answers to our questions. Afterall for the preliminary efforts, FIH 
behaves different in heavy water, probably showing an inverse SIE.  
 
CTAD inhibition at high concentrations might be due to stronger hydrogen bonding 
interactions in heavy water, so product release after hydroxylation might be prevented. 
To test this behaviour, really high concentrations of CTAD should be tested for any 
inhibition in H2O.  
 
If the water release upon CTAD binding is the rate limiting step, it would help us to 
better understand the regulatory role of FIH. It would also elucidate how oxygen is 
activated. In the absence of substrate, oxygen can still bind to iron center and do slow 
oxidative reaction like auto-hydroxylation. When the substrate is present, water release 
opens a coordination site for oxygen binding.   Determining the rate limiting step for 
oxygen activation  will provide more insights into oxygen sensor FIH and other nonheme 
iron enzymes in which oxygen is activated in a controlled manner.  
 
As we have seen in the previous chapters there is not only one factor for oxygen 
activation. In chapter 2; how activated oxygen is tightly coupled to CTAD hydroxylation 
in FIH was tested, in chapter 3; the impact of hydrogen bonding network on the second 
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coordination sphere was studied and in chapter 4; the rate determining step for the 
oxygen activation was investigated by means of solvent isotope studies.  
 
Overall this thesis provided insights into how oxygen is activated and controlled in FIH 
which is one of the primary oxygen sensors in human body. Understanding the 
mechanism of how activated oxygen is controlled in human oxygen sensor FIH would 
draw new pathways in hypoxia sensing and its related diseases.   
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